RxNorm Semantic Concepts Index - 247
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "247".
RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
RxCUI: 2470003 | zinc pyrithione 2 MG/ML [Head & Shoulders] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2470004 | Head & Shoulders 0.2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2470004 | Head & Shoulders 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2470004 | Head & Shoulders 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2470004 | Head & Shoulders 0.2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2470030 | Agastache foeniculum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2470031 | Baptisia australis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2470130 | Solanum nigrum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 247018 | dimenhyDRINATE 2.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247018 | dimenhyDRINATE 2.5 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2470230 | ethanol 0.748 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2470231 | ethanol 74.8 % / benzalkonium chloride 0.1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2470231 | ethanol 74.8 % / benzalkonium chloride 0.1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2470232 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2470233 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2470234 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 100 MCG/0.5 ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2470234 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 100 MCG/0.5 ML Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2470234 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 100 MCG/0.5 ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247035 | penicillin G 100000 UNT/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247036 | penicillin V 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247037 | bacampicillin 800 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247038 | cloxacillin 132 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247039 | cloxacillin 294 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247040 | pyrvinium 10 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247042 | budesonide 50 MCG/ACTUAT Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247042 | budesonide 50 MCG/ACTUAT Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247042 | budesonide 50 MCG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247042 | budesonide 50 MCG/ACTUAT Nasal Spray | Designated preferred name (PT) | NO | |
RxCUI: 247042 | budesonide 50 MCG/ACTUAT Nasal Spray | Full form of descriptor (FN) | NO | |
RxCUI: 247044 | albuterol 0.05 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247046 | theophylline 325 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247047 | budesonide 200 MCG/ACTUAT Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247047 | budesonide 200 MCG/ACTUAT Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247047 | budesonide 200 MCG/ACTUAT Inhalation Powder | Designated preferred name (PT) | NO | |
RxCUI: 247047 | budesonide 200 MCG/ACTUAT Inhalation Powder | Designated preferred name (PT) | NO | |
RxCUI: 247047 | budesonide 200 MCG/ACTUAT Inhalation Powder | Full form of descriptor (FN) | NO | |
RxCUI: 247047 | budesonide 200 MCG/ACTUAT Inhalation Powder | Full form of descriptor (FN) | NO | |
RxCUI: 247049 | fiber 469 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247050 | lactulose 0.4 MG/MG Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247051 | diphenoxylate 0.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247052 | aluminum hydroxide 80 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247053 | aluminum hydroxide 20 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2470531 | behenyl betaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2470532 | Cyclavance | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2470533 | cyclosporine, modified 100 MG/ML [Cyclavance] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2470533 | cyclosporine, modified 100 MG/ML [Cyclavance] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2470534 | cyclosporine Oral Solution [Cyclavance] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2470534 | cyclosporine Oral Solution [Cyclavance] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2470535 | Cyclavance Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2470536 | Cyclavance Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2470537 | Cyclavance 100 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2470537 | Cyclavance 100 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2470537 | Cyclavance 100 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2470537 | Cyclavance 100 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2470538 | dimethicone/peg-10/15 crosspolymer in dimethicone 6 (130000 cps) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 247054 | mesalamine 500 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247054 | mesalamine 500 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247055 | metroNIDAZOLE 10 % Vaginal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247055 | metroNIDAZOLE 10 % Vaginal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247055 | metroNIDAZOLE 10 % Vaginal Cream | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 247055 | metroNIDAZOLE 10 % Vaginal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247055 | metroNIDAZOLE 10 % Vaginal Cream | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 247057 | methotrimeprazine 5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247058 | methotrimeprazine 40 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247059 | periciazine 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247059 | periciazine 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247060 | periciazine 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247060 | periciazine 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247061 | periciazine 10 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247066 | piroxicam 10 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247066 | piroxicam 10 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247069 | indomethacin 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247069 | indomethacin 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247069 | indomethacin 1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247070 | betamethasone 0.05 MG/ML Enema | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247071 | erythromycin 0.04 MG/MG / tretinoin 0.00025 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247072 | beclomethasone 0.25 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247073 | flumethasone pivalate 0.03 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247073 | flumethasone pivalate 0.03 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247073 | flumethasone pivalate 0.03 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247074 | aluminum acetate 3.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247075 | Carbachol 250 microgram/mL solution for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247075 | Carbachol 250 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 247075 | Carbachol 250 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 247076 | indomethacin 10 MG/ML Ophthalmic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247079 | shark liver oil 0.03 MG/MG / tissue respiratory factor 2000 UNT Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247086 | amylase 58,500 UNT / lipase 18,000 UNT / protease 58,500 UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247086 | amylase 58,500 UNT / lipase 18,000 UNT / protease 58,500 UNT Oral Capsule | Designated preferred name (PT) | NO | |
RxCUI: 247086 | amylase 58,500 UNT / lipase 18,000 UNT / protease 58,500 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247086 | amylase 58,500 UNT / lipase 18,000 UNT / protease 58,500 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247086 | amylase 58,500 UNT / lipase 18,000 UNT / protease 58,500 UNT Oral Capsule | Full form of descriptor (FN) | NO | |
RxCUI: 2470932 | benzalkonium chloride 0.05 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2470932 | benzalkonium chloride 0.05 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2470932 | benzalkonium chloride 0.05 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2470934 | imidacloprid 100 MG/ML / moxidectin 10 MG/ML [Imoxi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2470935 | IMOXI 10 % / 1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2470935 | IMOXI 10 % / 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2470935 | IMOXI 10 % / 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247094 | allyl sulfide 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247096 | coal tar 10 % / salicylic acid 6 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247096 | coal tar 10 % / salicylic acid 6 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 24710 | Complement factor Bb | Designated preferred name (PT) | NO | |
RxCUI: 24710 | Complement factor Bb | Full form of descriptor (FN) | NO | |
RxCUI: 247105 | guaiFENesin 50 MG / phenylpropanolamine HCl 6.25 MG per 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247105 | guaiFENesin 50 MG / phenylpropanolamine HCl 6.25 MG per 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 247105 | guaiFENesin 50 MG / phenylpropanolamine HCl 6.25 MG per 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247105 | guaiFENesin 50 MG / phenylpropanolamine HCl 6.25 MG per 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247105 | guaiFENesin 50 MG / phenylpropanolamine HCl 6.25 MG per 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2471077 | Acer saccharum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2471078 | tirbanibulin | Full form of descriptor (FN) | YES | |
RxCUI: 2471078 | tirbanibulin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2471078 | tirbanibulin | Designated preferred name (PT) | YES | |
RxCUI: 2471078 | tirbanibulin | Full form of descriptor (FN) | YES | |
RxCUI: 2471078 | tirbanibulin | Designated preferred name (PT) | YES | |
RxCUI: 2471079 | 1,1-diphenylurea | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2471080 | amodimethicone (240 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2471082 | bovine type II collagen (tracheal cartilage) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2471083 | Collagen type II | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2471083 | Collagen type II | Designated preferred name (PT) | NO | |
RxCUI: 2471083 | Collagen type II | Full form of descriptor (FN) | NO | |
RxCUI: 2471084 | Callitris columellaris wood oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2471085 | propylene glycol t-butyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2471086 | pyrroloquinolinedione tricarboxylic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2471087 | surfactant protein-D homotrimer, recombinant fragment human | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2471088 | surfactant protein-D homotrimer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2471089 | sodium chloride dihyrdate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2471090 | sodium laureth-6 carboxylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2471091 | laureth-6 carboxylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2471092 | tirbanibulin 0.01 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2471093 | tirbanibulin Topical Product | Full form of descriptor (FN) | YES | |
RxCUI: 2471093 | tirbanibulin Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2471093 | tirbanibulin Topical Product | Designated preferred name (PT) | YES | |
RxCUI: 2471094 | tirbanibulin Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2471095 | tirbanibulin 1 % Topical Ointment | Full form of descriptor (FN) | YES | |
RxCUI: 2471095 | tirbanibulin 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2471095 | tirbanibulin 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2471095 | tirbanibulin 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2471095 | tirbanibulin 1 % Topical Ointment | Designated preferred name (PT) | YES | |
RxCUI: 2471096 | Klisyri | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2471097 | tirbanibulin 0.01 MG/MG [Klisyri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2471098 | tirbanibulin Topical Ointment [Klisyri] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2471099 | Klisyri Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2471100 | Klisyri 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2471100 | Klisyri 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2471100 | Klisyri 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2471100 | Klisyri 1 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2471105 | adapalene / benzoyl peroxide Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2471106 | adapalene / benzoyl peroxide Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2471107 | adapalene 0.1 % / benzoyl peroxide 2.5 % Swab | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2471107 | adapalene 0.1 % / benzoyl peroxide 2.5 % Swab | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2471107 | adapalene 0.1 % / benzoyl peroxide 2.5 % Swab | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 247122 | nilutamide 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247122 | nilutamide 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247123 | sucralfate 200 MG/mL Oral Suspension | Full form of descriptor (FN) | NO | |
RxCUI: 247123 | sucralfate 200 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247123 | sucralfate 200 MG/mL Oral Suspension | Designated preferred name (PT) | NO | |
RxCUI: 247123 | sucralfate 200 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247127 | iron sorbitex 50 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247128 | pipemidic acid 400 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247129 | phenolphthalein 100 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2471302 | .beta.-amyloid protein-(1-6)-peptidylglycylglycyl-L-cysteine-3-(2,5-dioxo-2,5-dihydro-1H-pyrrole-1-yl)-n-(6-((2,5-dioxopyrrolidin-1-yl)oxy)-6-oxohexyl)propanamide-alanine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2471303 | triethoxysilylpropyl steardimonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2471304 | octadecyl di-tert-butyl-4-hydroxyhydrocinnamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2471306 | ethanol 94 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2471306 | ethanol 94 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2471306 | ethanol 94 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2471310 | sodium monofluorophosphate 0.0072 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2471311 | sodium monofluorophosphate 0.72 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2471311 | sodium monofluorophosphate 0.72 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2471311 | sodium monofluorophosphate 0.72 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2471314 | Tri-Nymyo 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2471314 | Tri-Nymyo 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2471314 | Tri-Nymyo 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247137 | aspirin 650 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247137 | aspirin 650 MG Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247137 | aspirin 650 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247138 | ASA 850 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247138 | ASA 850 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247139 | sulfur 8 % / resorcinol 2 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247139 | sulfur 8 % / resorcinol 2 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247139 | sulfur 8 % / resorcinol 2 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247140 | coal tar 20 MG/ML / salicylic acid 30 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2471402 | petrolatum 0.99 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2471403 | petrolatum 99 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2471403 | petrolatum 99 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2471403 | petrolatum 99 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2471404 | menthol 10.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2471404 | menthol 10.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2471404 | menthol 10.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2471430 | Lactobacillus fermentum | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2471430 | Lactobacillus fermentum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2471431 | ocean perch preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2471432 | ethanol 94 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2471432 | ethanol 94 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2471432 | ethanol 94 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247145 | benzocaine 5 % / tannic acid 6 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247145 | benzocaine 5 % / tannic acid 6 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247145 | benzocaine 5 % / tannic acid 6 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247147 | piperonyl butoxide 2.2 % / pyrethrins 0.18 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247147 | piperonyl butoxide 2.2 % / pyrethrins 0.18 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247147 | piperonyl butoxide 2.2 % / pyrethrins 0.18 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247149 | pancreatin 300 MG / pepsin A 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247153 | calcium carbonate 311 MG / magnesium carbonate 232 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247161 | mesalamine 250 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247161 | mesalamine 250 MG Rectal Suppository | Designated preferred name (PT) | NO | |
RxCUI: 247161 | mesalamine 250 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247161 | mesalamine 250 MG Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247161 | mesalamine 250 MG Rectal Suppository | Full form of descriptor (FN) | NO | |
RxCUI: 2471704 | Rattus norvegicus hair preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2471705 | glycerin 1,3-dimethyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2471867 | hydroxyethyl palmityl oxyhydroxypropyl palmitamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2471868 | Rosa X alba flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2471869 | sodium linoleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2471870 | Inula helnium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2471871 | betamethasone dipropionate 0.64 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2471872 | betamethasone / calcipotriene Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2471873 | betamethasone dipropionate 0.064 % / calcipotriene 0.005 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2471873 | betamethasone dipropionate 0.064 % / calcipotriene 0.005 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2471873 | betamethasone dipropionate 0.064 % / calcipotriene 0.005 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2471874 | Wynzora | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2471875 | betamethasone dipropionate 0.64 MG/ML / calcipotriene 0.05 MG/ML [Wynzora] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2471876 | betamethasone / calcipotriene Topical Cream [Wynzora] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2471877 | Wynzora Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2471878 | Wynzora 0.005 % / 0.064 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2471878 | Wynzora 0.005 % / 0.064 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2471878 | Wynzora 0.005 % / 0.064 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2471879 | lasmiditan 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2471880 | lasmiditan 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2471880 | lasmiditan 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2471881 | lasmiditan 200 MG [Reyvow] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2471882 | Reyvow 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2471882 | Reyvow 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2471882 | Reyvow 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2471883 | Gleptosil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2471884 | iron-dextran complex 200 MG/ML [Gleptosil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2471885 | iron-dextran complex Injectable Solution [Gleptosil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2471886 | Gleptosil Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2471887 | Gleptosil 200 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2471887 | Gleptosil 200 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2471887 | Gleptosil 200 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2471888 | Ursoferran | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2471889 | iron-dextran complex 200 MG/ML [Ursoferran] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2471890 | iron-dextran complex Injectable Solution [Ursoferran] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2471891 | Ursoferran Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2471892 | Ursoferran 200 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2471892 | Ursoferran 200 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2471892 | Ursoferran 200 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2471955 | lidocaine hydrochloride 4 % / menthol 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2471955 | lidocaine hydrochloride 4 % / menthol 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2471955 | lidocaine hydrochloride 4 % / menthol 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2471957 | benzocaine / povidone-iodine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2472 | Chondroitin sulfate lyase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2472 | Chondroitin sulfate lyase | Designated preferred name (PT) | NO | |
RxCUI: 2472 | Chondroitin sulfate lyase | Full form of descriptor (FN) | NO | |
RxCUI: 2472 | Chondroitin sulfate lyase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2472 | Chondroitin sulfate lyase | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 2472102 | ethanol 0.723 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2472103 | ethanol 72.34 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2472103 | ethanol 72.34 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2472103 | ethanol 72.34 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2472149 | hydrogen peroxide 38 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2472150 | hydrogen peroxide 3.8 % Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2472150 | hydrogen peroxide 3.8 % Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2472150 | hydrogen peroxide 3.8 % Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2472151 | ansuvimab-zykl | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2472152 | ansuvimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2472152 | ansuvimab | Designated preferred name (PT) | YES | |
RxCUI: 2472152 | ansuvimab | Full form of descriptor (FN) | YES | |
RxCUI: 2472152 | ansuvimab | Designated preferred name (PT) | YES | |
RxCUI: 2472152 | ansuvimab | Full form of descriptor (FN) | YES | |
RxCUI: 2472153 | ansuvimab-zykl 400 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2472154 | ansuvimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2472154 | ansuvimab Injectable Product | Designated preferred name (PT) | YES | |
RxCUI: 2472154 | ansuvimab Injectable Product | Full form of descriptor (FN) | YES | |
RxCUI: 2472155 | ansuvimab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2472156 | ansuvimab-zykl 400 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2472156 | ansuvimab-zykl 400 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2472157 | Ebanga | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2472158 | ansuvimab-zykl 400 MG [Ebanga] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2472159 | ansuvimab Injection [Ebanga] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2472160 | Ebanga Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2472161 | ebanga 400 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2472161 | ebanga 400 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2472161 | ebanga 400 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2472162 | povidone-iodine 0.07 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2472163 | benzocaine 5 % / povidone-iodine 7 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2472163 | benzocaine 5 % / povidone-iodine 7 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2472163 | benzocaine 5 % / povidone-iodine 7 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2472164 | benzocaine / povidone-iodine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 2472165 | benzocaine / povidone-iodine Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2472167 | iodine 10 MG/ML [Dairyland Brand Controlled Iodine Teat Dip] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2472169 | urea 200 MG/ML [Carmol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2472170 | urea Topical Cream [Carmol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2472172 | urea 0.4 MG/MG [Carmol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2472173 | urea Topical Gel [Carmol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2472175 | urea 400 MG/ML [Carmol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 247218 | 12 HR guaifenesin 0.00667 MG/MG / theophylline 0.02 MG/MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247218 | 12 HR guaifenesin 0.00667 MG/MG / theophylline 0.02 MG/MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2472186 | heptane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2472254 | vibegron | Full form of descriptor (FN) | YES | |
RxCUI: 2472254 | vibegron | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2472254 | vibegron | Designated preferred name (PT) | YES | |
RxCUI: 2472254 | vibegron | Full form of descriptor (FN) | YES | |
RxCUI: 2472254 | vibegron | Designated preferred name (PT) | YES | |
RxCUI: 2472307 | Dolishale 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2472307 | Dolishale 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2472307 | Dolishale 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2472310 | cinidon-ethyl | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2472311 | vibegron 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2472312 | vibegron Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 2472312 | vibegron Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2472312 | vibegron Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 2472313 | vibegron Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2472314 | vibegron Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2472315 | vibegron 75 MG Once-Daily Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 2472315 | vibegron 75 MG Once-Daily Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2472315 | vibegron 75 MG Once-Daily Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 2472315 | vibegron 75 MG Once-Daily Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2472316 | Gemtesa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2472317 | vibegron 75 MG [Gemtesa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2472318 | vibegron Oral Tablet [Gemtesa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2472319 | Gemtesa Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2472320 | Gemtesa Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2472321 | GEMTESA 75 MG Once-Daily Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2472321 | GEMTESA 75 MG Once-Daily Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2472321 | GEMTESA 75 MG Once-Daily Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2472322 | Triethyleneglycol dimethacrylate | Full form of descriptor (FN) | NO | |
RxCUI: 2472322 | Triethyleneglycol dimethacrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2472322 | Triethyleneglycol dimethacrylate | Designated preferred name (PT) | NO | |
RxCUI: 2472322 | Triethyleneglycol dimethacrylate | Full form of descriptor (FN) | NO | |
RxCUI: 2472322 | Triethyleneglycol dimethacrylate | Designated preferred name (PT) | NO | |
RxCUI: 2472323 | cholecalciferol 0.625 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2472324 | cholecalciferol 0.625 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2472324 | cholecalciferol 0.625 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2472324 | cholecalciferol 0.625 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2472325 | rituximab-arrx | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2472325 | rituximab-arrx | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2472326 | rituximab-arrx 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2472326 | rituximab-arrx 10 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2472327 | riTUXimab-arrx 100 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2472327 | riTUXimab-arrx 100 MG in 10 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2472327 | riTUXimab-arrx 100 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2472327 | riTUXimab-arrx 100 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2472327 | riTUXimab-arrx 100 MG in 10 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2472328 | Riabni | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2472329 | rituximab-arrx 10 MG/ML [Riabni] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2472329 | rituximab-arrx 10 MG/ML [Riabni] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2472330 | rituximab Injection [Riabni] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2472330 | rituximab Injection [Riabni] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2472331 | Riabni Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2472332 | RIABNI 100 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2472332 | RIABNI 100 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2472332 | RIABNI 100 MG in 10 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2472332 | RIABNI 100 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2472332 | RIABNI 100 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2472333 | rituximab-arrx 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2472333 | rituximab-arrx 10 MG/ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2472334 | rituximab-arrx 10 MG/ML Injection [Riabni] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2472334 | rituximab-arrx 10 MG/ML Injection [Riabni] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2472334 | rituximab-arrx 10 MG/ML Injection [Riabni] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2472335 | riTUXimab-arrx 500 MG in 50 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2472335 | riTUXimab-arrx 500 MG in 50 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2472335 | riTUXimab-arrx 500 MG in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2472335 | riTUXimab-arrx 500 MG in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2472335 | riTUXimab-arrx 500 MG in 50 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2472336 | RIABNI 500 MG in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2472336 | RIABNI 500 MG in 50 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2472336 | RIABNI 500 MG in 50 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2472336 | RIABNI 500 MG in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2472336 | RIABNI 500 MG in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2472338 | diphenhydramine hydrochloride 10 MG/ML / zinc acetate 1 MG/ML [Wal-Dryl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2472338 | diphenhydramine hydrochloride 10 MG/ML / zinc acetate 1 MG/ML [Wal-Dryl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2472339 | Wal-Dryl 1 % / 0.1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2472339 | Wal-Dryl 1 % / 0.1 % Topical Cream | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2472339 | Wal-Dryl 1 % / 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2472339 | Wal-Dryl 1 % / 0.1 % Topical Cream | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2472339 | Wal-Dryl 1 % / 0.1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2472364 | carboxymethylcellulose 1.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2472365 | carboxymethylcellulose Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2472366 | carboxymethylcellulose Medicated Patch | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2472367 | carboxymethylcellulose 1.5 MG Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2472367 | carboxymethylcellulose 1.5 MG Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 24724 | Coagulation factor V antigen | Designated preferred name (PT) | NO | |
RxCUI: 24724 | Coagulation factor V antigen | Full form of descriptor (FN) | NO | |
RxCUI: 247252 | hydrogen peroxide 1.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247252 | hydrogen peroxide 1.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247252 | hydrogen peroxide 1.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 24726 | Coagulation factor VII antigen | Designated preferred name (PT) | NO | |
RxCUI: 24726 | Coagulation factor VII antigen | Full form of descriptor (FN) | NO | |
RxCUI: 2472775 | .alpha.-citronellal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2472776 | stearyl acrylate polymer (110000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2472777 | Ipomoea batatas whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2472778 | relugolix | Full form of descriptor (FN) | YES | |
RxCUI: 2472778 | relugolix | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2472778 | relugolix | Designated preferred name (PT) | YES | |
RxCUI: 2472778 | relugolix | Full form of descriptor (FN) | YES | |
RxCUI: 2472778 | relugolix | Designated preferred name (PT) | YES | |
RxCUI: 2472779 | relugolix 120 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2472780 | relugolix Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 2472780 | relugolix Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2472780 | relugolix Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 2472781 | relugolix Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2472782 | relugolix Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2472783 | relugolix 120 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 2472783 | relugolix 120 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2472783 | relugolix 120 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 2472783 | relugolix 120 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2472784 | Orgovyx | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2472785 | relugolix 120 MG [Orgovyx] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2472786 | relugolix Oral Tablet [Orgovyx] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2472787 | Orgovyx Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2472788 | Orgovyx Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2472789 | ORGOVYX 120 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2472789 | ORGOVYX 120 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2472789 | ORGOVYX 120 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2472790 | trastuzumab-qyyp 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2472791 | trastuzumab-qyyp 150 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2472791 | trastuzumab-qyyp 150 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2472792 | trastuzumab-qyyp 150 MG [Trazimera] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2472793 | trastuzumab Injection [Trazimera] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2472794 | Trazimera 150 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2472794 | Trazimera 150 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2472794 | Trazimera 150 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2472795 | polyoxyl 15 hydroxystearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2472898 | Imidazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2472898 | Imidazole | Designated preferred name (PT) | NO | |
RxCUI: 2472898 | Imidazole | Full form of descriptor (FN) | NO | |
RxCUI: 2472898 | Imidazole | Designated preferred name (PT) | NO | |
RxCUI: 2472898 | Imidazole | Full form of descriptor (FN) | NO | |
RxCUI: 247293 | dexamethasone 3.2 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247293 | dexamethasone 3.2 MG/ML Injectable Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 247294 | benzocaine 7.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247294 | benzocaine 7.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247294 | benzocaine 7.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2473 | Chondroitin sulfate | Designated preferred name (PT) | YES | |
RxCUI: 2473 | Chondroitin sulfate | Full form of descriptor (FN) | YES | |
RxCUI: 2473 | Chondroitin sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2473 | Chondroitin sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
RxCUI: 2473039 | ponatinib 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2473039 | ponatinib 10 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2473040 | PONATinib 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2473040 | PONATinib 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2473040 | PONATinib 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2473040 | PONATinib 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2473040 | PONATinib 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2473041 | ponatinib 10 MG [Iclusig] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2473041 | ponatinib 10 MG [Iclusig] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2473042 | Iclusig 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2473042 | Iclusig 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2473042 | Iclusig 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2473042 | Iclusig 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 247305 | caffeine 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247308 | benzyl alcohol 10 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247308 | benzyl alcohol 10 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247308 | benzyl alcohol 10 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2473106 | isotretinoin 30 MG [Accutane] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2473106 | isotretinoin 30 MG [Accutane] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2473107 | ACCUTANE 30 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2473107 | ACCUTANE 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2473107 | ACCUTANE 30 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2473107 | ACCUTANE 30 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 247313 | tolnaftate 1 % / triacetin 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247313 | tolnaftate 1 % / triacetin 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247313 | tolnaftate 1 % / triacetin 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2473230 | paclitaxel poliglumex | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2473230 | paclitaxel poliglumex | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2473231 | Solidago velutina whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 247324 | acetaminophen 500 MG /dextromethorphan HBr 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 247324 | acetaminophen 500 MG /dextromethorphan HBr 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 247324 | acetaminophen 500 MG /dextromethorphan HBr 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247324 | acetaminophen 500 MG /dextromethorphan HBr 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2473276 | levothyroxine sodium 100 MCG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2473276 | levothyroxine sodium 100 MCG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2473276 | levothyroxine sodium 100 MCG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2473276 | levothyroxine sodium 100 MCG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2473276 | levothyroxine sodium 100 MCG in 5 mL Oral Solution | Designated preferred name (PT) | YES | |
RxCUI: 2473276 | levothyroxine sodium 100 MCG in 5 mL Oral Solution | Full form of descriptor (FN) | YES | |
RxCUI: 2473277 | Thyquidity | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2473278 | levothyroxine sodium 0.02 MG/ML [Thyquidity] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2473279 | levothyroxine Oral Solution [Thyquidity] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2473280 | Thyquidity Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2473281 | Thyquidity Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2473282 | Thyquidity 100 MCG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2473282 | Thyquidity 100 MCG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2473282 | Thyquidity 100 MCG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2473282 | Thyquidity 100 MCG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2473282 | Thyquidity 100 MCG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2473283 | glucose 15000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2473284 | glucose 15 GM Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2473284 | glucose 15 GM Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2473284 | glucose 15 GM Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247330 | amylase 750 UNT / lipase 350 UNT / protease 3750 UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247333 | chromium picolinate 1.67 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247334 | piperonyl butoxide 10 MG/ML / pyrethrins 2 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2473372 | camphor 5.9 % / menthol 0.8 % / methyl salicylate 4.6 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2473372 | camphor 5.9 % / menthol 0.8 % / methyl salicylate 4.6 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2473372 | camphor 5.9 % / menthol 0.8 % / methyl salicylate 4.6 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2473373 | camphor 2 % / lidocaine 4 % / methyl salicylate 4 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2473373 | camphor 2 % / lidocaine 4 % / methyl salicylate 4 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2473373 | camphor 2 % / lidocaine 4 % / methyl salicylate 4 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2473374 | 1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol 2000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2473375 | alpha, alpha'-diglycerol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2473379 | ethanol 80 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2473379 | ethanol 80 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2473379 | ethanol 80 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2473383 | glycopyrrolate 0.6 MG in 3 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2473383 | glycopyrrolate 0.6 MG in 3 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2473383 | glycopyrrolate 0.6 MG in 3 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2473384 | Glyrx-PF 0.6 MG in 3 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2473384 | Glyrx-PF 0.6 MG in 3 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2473384 | Glyrx-PF 0.6 MG in 3 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2473384 | Glyrx-PF 0.6 MG in 3 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247340 | dihydroxyacetone 6.55 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247340 | dihydroxyacetone 6.55 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247340 | dihydroxyacetone 6.55 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2473417 | camphor 3 % / menthol 2 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2473417 | camphor 3 % / menthol 2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2473417 | camphor 3 % / menthol 2 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 24735 | Flavin-adenine dinucleotide (FAD) pyrophosphatase | Designated preferred name (PT) | NO | |
RxCUI: 24735 | Flavin-adenine dinucleotide (FAD) pyrophosphatase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 24735 | Flavin-adenine dinucleotide (FAD) pyrophosphatase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 24735 | Flavin-adenine dinucleotide (FAD) pyrophosphatase | Full form of descriptor (FN) | NO | |
RxCUI: 247350 | gentamicin (as gentamicin sulfate) 0.3 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247350 | gentamicin (as gentamicin sulfate) 0.3 % Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247352 | hydrocortisone 0.0075 MG/MG Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247355 | pilocarpine 2 % / timolol 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247355 | pilocarpine 2 % / timolol 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247355 | pilocarpine 2 % / timolol 0.5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247356 | pilocarpine 4 % / timolol 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247356 | pilocarpine 4 % / timolol 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247356 | pilocarpine 4 % / timolol 0.5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247363 | periciazine 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247363 | periciazine 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247365 | calcium ascorbate 850 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247366 | carboxymethylcellulose 300 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247368 | thiopropazate 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247372 | ASA 325 MG / Codeine 8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247372 | ASA 325 MG / Codeine 8 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247375 | alloin 15 MG / phenolphthalein 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247376 | alloin 8 MG / phenolphthalein 16 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2473841 | dimethyltetradecyl(3-(trimethoxysilyl)propyl)ammonium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2473844 | ethanethioic acid, S-(1-((1E)-2-hydroxyethenyl)butyl) ester | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2473847 | ethanol 0.91 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2473848 | ethanol 91 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2473848 | ethanol 91 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2473848 | ethanol 91 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2473850 | margetuximab-cmkb | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2473851 | margetuximab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2473851 | margetuximab | Designated preferred name (PT) | YES | |
RxCUI: 2473851 | margetuximab | Full form of descriptor (FN) | YES | |
RxCUI: 2473851 | margetuximab | Designated preferred name (PT) | YES | |
RxCUI: 2473851 | margetuximab | Full form of descriptor (FN) | YES | |
RxCUI: 247390 | calcium gluceptate 132 MG/ML / calcium gluconate 112 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247392 | chloroxylenol 100 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247393 | chloroxylenol 50 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247394 | chloroxylenol 0.25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247394 | chloroxylenol 0.25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247394 | chloroxylenol 0.25 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247395 | chloroxylenol 6 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247396 | chloroxylenol 3 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 247396 | chloroxylenol 3 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247396 | chloroxylenol 3 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 247399 | 4-cresyl acetate 1000 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247400 | cresol 12.5 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2474006 | olopatadine 7 MG/ML [Pataday] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2474007 | Pataday 0.7 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2474007 | Pataday 0.7 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2474007 | Pataday 0.7 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247402 | isopropyl alcohol 90 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 247402 | isopropyl alcohol 90 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 247402 | isopropyl alcohol 90 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474025 | margetuximab-cmkb 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2474026 | margetuximab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2474026 | margetuximab Injectable Product | Designated preferred name (PT) | YES | |
RxCUI: 2474026 | margetuximab Injectable Product | Full form of descriptor (FN) | YES | |
RxCUI: 2474027 | margetuximab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2474028 | margetuximab-cmkb 250 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2474028 | margetuximab-cmkb 250 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2474028 | margetuximab-cmkb 250 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474029 | Margenza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2474030 | margetuximab-cmkb 25 MG/ML [Margenza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2474031 | margetuximab Injection [Margenza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2474032 | Margenza Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2474033 | Margenza 250 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474033 | Margenza 250 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2474033 | Margenza 250 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2474033 | Margenza 250 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474034 | margetuximab-cmkb 25 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2474035 | margetuximab-cmkb 25 MG/ML Injection [Margenza] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2474035 | margetuximab-cmkb 25 MG/ML Injection [Margenza] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2474038 | Mentha suaveolens leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2474039 | naxitamab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2474039 | naxitamab | Designated preferred name (PT) | YES | |
RxCUI: 2474039 | naxitamab | Full form of descriptor (FN) | YES | |
RxCUI: 2474039 | naxitamab | Designated preferred name (PT) | YES | |
RxCUI: 2474039 | naxitamab | Full form of descriptor (FN) | YES | |
RxCUI: 247404 | magnesium sulfate 137 MG/ML / peptones 30 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247405 | sodium selenite 0.04 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247410 | paregoric 0.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247418 | betamethasone 1 MG/ML / sulfacetamide 100 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247419 | chloramphenicol 2 MG/ML / hydrocortisone 10 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247423 | normethadone 10 MG/ML / oxilofrine 20 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2474235 | naxitamab-gqgk | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2474236 | naxitamab-gqgk 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2474237 | naxitamab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2474237 | naxitamab Injectable Product | Designated preferred name (PT) | YES | |
RxCUI: 2474237 | naxitamab Injectable Product | Full form of descriptor (FN) | YES | |
RxCUI: 2474238 | naxitamab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2474239 | naxitamab-gqgk 40 MG per 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2474239 | naxitamab-gqgk 40 MG per 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2474239 | naxitamab-gqgk 40 MG per 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474240 | Danyelza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2474241 | naxitamab-gqgk 4 MG/ML [Danyelza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2474242 | naxitamab Injection [Danyelza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2474243 | Danyelza Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2474244 | DANYELZA 40 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474244 | DANYELZA 40 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2474244 | DANYELZA 40 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2474244 | DANYELZA 40 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474245 | naxitamab-gqgk 4 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2474246 | naxitamab-gqgk 4 MG/ML Injection [Danyelza] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2474246 | naxitamab-gqgk 4 MG/ML Injection [Danyelza] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2474262 | oxymetazoline hydrochloride 0.0005 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2474263 | oxymetazoline Nasal Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2474264 | oxymetazoline hydrochloride 0.05 % Nasal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474264 | oxymetazoline hydrochloride 0.05 % Nasal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2474264 | oxymetazoline hydrochloride 0.05 % Nasal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2474266 | fentanyl Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2474266 | fentanyl Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2474267 | fentaNYL 100 MCG in 2 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2474267 | fentaNYL 100 MCG in 2 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2474267 | fentaNYL 100 MCG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474267 | fentaNYL 100 MCG in 2 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2474267 | fentaNYL 100 MCG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2474267 | fentaNYL 100 MCG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474267 | fentaNYL 100 MCG in 2 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2474268 | fentanyl 0.05 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2474268 | fentanyl 0.05 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2474269 | fentaNYL 0.05 MG in1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2474269 | fentaNYL 0.05 MG in1 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2474269 | fentaNYL 0.05 MG in1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474269 | fentaNYL 0.05 MG in1 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2474269 | fentaNYL 0.05 MG in1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2474269 | fentaNYL 0.05 MG in1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474269 | fentaNYL 0.05 MG in1 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 247428 | magnesium sulfate 400 MG/ML / peptones 80 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247429 | benzalkonium 1.4 MG/ML / lidocaine 26 MG/ML Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247430 | benzethonium 1.5 MG/ML / benzocaine 45 MG/ML Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247432 | ZNO 125 MG/ML Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247432 | ZNO 125 MG/ML Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2474330 | citric acid 1530 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2474331 | sodium bicarbonate 2210 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2474332 | citric acid / simethicone / sodium bicarbonate Granules for Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2474333 | citric acid 1.53 GM / simethicone 0.04 GM / sodium bicarbonate 2.21 GM Effervescent Granules for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2474333 | citric acid 1.53 GM / simethicone 0.04 GM / sodium bicarbonate 2.21 GM Effervescent Granules for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474333 | citric acid 1.53 GM / simethicone 0.04 GM / sodium bicarbonate 2.21 GM Effervescent Granules for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474333 | citric acid 1.53 GM / simethicone 0.04 GM / sodium bicarbonate 2.21 GM Effervescent Granules for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2474334 | E-Z-Gas II | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2474335 | citric acid 1530 MG / simethicone 40 MG / sodium bicarbonate 2210 MG [E-Z-Gas II] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2474336 | citric acid / simethicone / sodium bicarbonate Granules for Oral Solution [E-Z-Gas II] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2474337 | E-Z-Gas II Granule Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2474338 | E-Z-Gas II Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2474339 | E-Z-Gas II 1.53 GM / 0.04 GM / 2.21 GM Effervescent Granules for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474339 | E-Z-Gas II 1.53 GM / 0.04 GM / 2.21 GM Effervescent Granules for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2474339 | E-Z-Gas II 1.53 GM / 0.04 GM / 2.21 GM Effervescent Granules for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2474340 | Clascoterone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2474340 | Clascoterone | Designated preferred name (PT) | YES | |
RxCUI: 2474340 | Clascoterone | Full form of descriptor (FN) | YES | |
RxCUI: 2474340 | Clascoterone | Designated preferred name (PT) | YES | |
RxCUI: 2474340 | Clascoterone | Full form of descriptor (FN) | YES | |
RxCUI: 2474344 | clascoterone 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2474344 | clascoterone 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474344 | clascoterone 1 % Topical Cream | Designated preferred name (PT) | YES | |
RxCUI: 2474344 | clascoterone 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2474344 | clascoterone 1 % Topical Cream | Full form of descriptor (FN) | YES | |
RxCUI: 2474345 | Winlevi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2474348 | Winlevi Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2474349 | Winlevi 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2474349 | Winlevi 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2474349 | Winlevi 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474349 | Winlevi 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247435 | beclomethasone 0.25 MG/ML / clioquinol 30 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247436 | betamethasone 1 MG/ML / neomycin 3.5 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247442 | betamethasone 1 MG/ML / neomycin 3.5 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247443 | betamethasone 0.5 MG/ML / salicylic acid 20 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2474485 | Lydexa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2474486 | lidocaine hydrochloride 41.2 MG/ML [Lydexa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2474487 | lidocaine Topical Cream [Lydexa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2474488 | Lydexa Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2474489 | Lydexa 4.12 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2474489 | Lydexa 4.12 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2474489 | Lydexa 4.12 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474489 | Lydexa 4.12 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247449 | beclomethasone 0.00025 MG/MG / clioquinol 0.03 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2474490 | camphor 40 MG/ML / menthol 75 MG/ML / methyl salicylate 100 MG/ML [Apeaz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2474491 | Apeaz Ultra 4 % / 7.5 % / 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2474491 | Apeaz Ultra 4 % / 7.5 % / 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2474491 | Apeaz Ultra 4 % / 7.5 % / 10 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2474494 | acetaminophen / aspirin / caffeine Effervescent Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2474495 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Effervescent Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2474495 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Effervescent Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2474495 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Effervescent Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2474497 | Indacaterol acetate | Designated preferred name (PT) | NO | |
RxCUI: 2474497 | Indacaterol acetate | Full form of descriptor (FN) | NO | |
RxCUI: 247450 | betamethasone 0.001 MG/MG / neomycin 0.0035 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2474502 | glucose Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2474503 | glucose Powder for Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2474504 | glucose 15 GM Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2474504 | glucose 15 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2474504 | glucose 15 GM Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 247451 | betamethasone 0.05 % / salicylic acid 3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247451 | betamethasone 0.05 % / salicylic acid 3 % Topical Ointment | Designated preferred name (PT) | NO | |
RxCUI: 247451 | betamethasone 0.05 % / salicylic acid 3 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247451 | betamethasone 0.05 % / salicylic acid 3 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247451 | betamethasone 0.05 % / salicylic acid 3 % Topical Ointment | Full form of descriptor (FN) | NO | |
RxCUI: 247452 | Chloramphenicol 1 % / Hydrocortisone 1 % Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247452 | Chloramphenicol 1 % / Hydrocortisone 1 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247463 | hexylresorcinol 2.4 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 247463 | hexylresorcinol 2.4 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 247463 | hexylresorcinol 2.4 MG Oral Lozenge | Designated preferred name (PT) | YES | |
RxCUI: 247463 | hexylresorcinol 2.4 MG Oral Lozenge | Full form of descriptor (FN) | YES | |
RxCUI: 2474630 | 1,1,1-triethoxyethane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2474631 | PEG-4 caprylic-capric glycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2474632 | Dodecafluoropentane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2474632 | Dodecafluoropentane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2474632 | Dodecafluoropentane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2474632 | Dodecafluoropentane | Designated preferred name (PT) | NO | |
RxCUI: 2474632 | Dodecafluoropentane | Full form of descriptor (FN) | NO | |
RxCUI: 2474632 | Dodecafluoropentane | Designated preferred name (PT) | NO | |
RxCUI: 2474632 | Dodecafluoropentane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2474632 | Dodecafluoropentane | Full form of descriptor (FN) | NO | |
RxCUI: 2474633 | silane, triethenylmethyl- | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2474633 | silane, triethenylmethyl- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2474634 | lidocaine Rectal Suppository | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2474635 | lidocaine 50 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2474635 | lidocaine 50 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 247479 | betamethasone 1 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247480 | betamethasone 1 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247483 | milk of magnesia 385 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247483 | milk of magnesia 385 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247484 | dexAMETHasone 0.1 % Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247484 | dexAMETHasone 0.1 % Ophthalmic Ointment | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 247484 | dexAMETHasone 0.1 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247484 | dexAMETHasone 0.1 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247484 | dexAMETHasone 0.1 % Ophthalmic Ointment | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 247495 | buserelin 0.1 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247495 | buserelin 0.1 % Injectable Solution | Designated preferred name (PT) | NO | |
RxCUI: 247495 | buserelin 0.1 % Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247495 | buserelin 0.1 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247495 | buserelin 0.1 % Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247495 | buserelin 0.1 % Injectable Solution | Full form of descriptor (FN) | NO | |
RxCUI: 24750 | Fansidar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2475073 | 1,3,5-triethylbenzene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2475074 | 3-(3-methyl-2-thienyl)acrylic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2475076 | cabotegravir sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2475076 | cabotegravir sodium | Designated preferred name (PT) | YES | |
RxCUI: 2475076 | cabotegravir sodium | Full form of descriptor (FN) | YES | |
RxCUI: 2475077 | cabotegravir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2475077 | cabotegravir | Designated preferred name (PT) | YES | |
RxCUI: 2475077 | cabotegravir | Full form of descriptor (FN) | YES | |
RxCUI: 2475077 | cabotegravir | Designated preferred name (PT) | YES | |
RxCUI: 2475077 | cabotegravir | Full form of descriptor (FN) | YES | |
RxCUI: 247508 | guaiFENesin 200 MG / phenylpropanolamine HCl 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247508 | guaiFENesin 200 MG / phenylpropanolamine HCl 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247508 | guaiFENesin 200 MG / phenylpropanolamine HCl 25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 247508 | guaiFENesin 200 MG / phenylpropanolamine HCl 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247508 | guaiFENesin 200 MG / phenylpropanolamine HCl 25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 247509 | Estrone 0.1 % Vaginal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247509 | Estrone 0.1 % Vaginal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247511 | Human isophane insulin 90 unit/mL and recombinant human soluble insulin 10 unit/mL suspension for injection | Designated preferred name (PT) | NO | |
RxCUI: 247511 | Human isophane insulin 90 unit/mL and recombinant human soluble insulin 10 unit/mL suspension for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247511 | Human isophane insulin 90 unit/mL and recombinant human soluble insulin 10 unit/mL suspension for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247511 | Human isophane insulin 90 unit/mL and recombinant human soluble insulin 10 unit/mL suspension for injection | Full form of descriptor (FN) | NO | |
RxCUI: 247512 | Human isophane insulin 80 unit/mL and recombinant human soluble insulin 20 unit/mL suspension for injection | Designated preferred name (PT) | NO | |
RxCUI: 247512 | Human isophane insulin 80 unit/mL and recombinant human soluble insulin 20 unit/mL suspension for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247512 | Human isophane insulin 80 unit/mL and recombinant human soluble insulin 20 unit/mL suspension for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247512 | Human isophane insulin 80 unit/mL and recombinant human soluble insulin 20 unit/mL suspension for injection | Full form of descriptor (FN) | NO | |
RxCUI: 247513 | Human isophane insulin 60 unit/mL and recombinant human soluble insulin 40 unit/mL suspension for injection | Designated preferred name (PT) | NO | |
RxCUI: 247513 | Human isophane insulin 60 unit/mL and recombinant human soluble insulin 40 unit/mL suspension for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247513 | Human isophane insulin 60 unit/mL and recombinant human soluble insulin 40 unit/mL suspension for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247513 | Human isophane insulin 60 unit/mL and recombinant human soluble insulin 40 unit/mL suspension for injection | Full form of descriptor (FN) | NO | |
RxCUI: 247514 | PGE2 0.000333 MG/MG Vaginal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247514 | PGE2 0.000333 MG/MG Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247515 | PGE2 0.000667 MG/MG Vaginal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247515 | PGE2 0.000667 MG/MG Vaginal Gel | Designated preferred name (PT) | NO | |
RxCUI: 247515 | PGE2 0.000667 MG/MG Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247515 | PGE2 0.000667 MG/MG Vaginal Gel | Full form of descriptor (FN) | NO | |
RxCUI: 247516 | captopril 6.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247516 | captopril 6.25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2475165 | isopropyl alcohol 80 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2475165 | isopropyl alcohol 80 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2475165 | isopropyl alcohol 80 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2475166 | voclosporin | Full form of descriptor (FN) | YES | |
RxCUI: 2475166 | voclosporin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2475166 | voclosporin | Designated preferred name (PT) | YES | |
RxCUI: 2475166 | voclosporin | Full form of descriptor (FN) | YES | |
RxCUI: 2475166 | voclosporin | Designated preferred name (PT) | YES | |
RxCUI: 2475167 | petrolatum 0.453 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2475168 | camphor 1.7 % / petrolatum, white 45.3 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2475168 | camphor 1.7 % / petrolatum, white 45.3 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2475168 | camphor 1.7 % / petrolatum, white 45.3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247517 | promethazine 20 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2475177 | Bifenthrin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2475177 | Bifenthrin | Designated preferred name (PT) | NO | |
RxCUI: 2475177 | Bifenthrin | Full form of descriptor (FN) | NO | |
RxCUI: 2475177 | Bifenthrin | Designated preferred name (PT) | NO | |
RxCUI: 2475177 | Bifenthrin | Full form of descriptor (FN) | NO | |
RxCUI: 2475178 | 1-phenylpropanol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475178 | 1-phenylpropanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2475179 | magnesium carbonate anhydrous | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2475179 | magnesium carbonate anhydrous | Designated preferred name (PT) | NO | |
RxCUI: 2475179 | magnesium carbonate anhydrous | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2475179 | magnesium carbonate anhydrous | Full form of descriptor (FN) | NO | |
RxCUI: 2475180 | sodium lauroyl glycinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2475182 | carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 2300 mpa.s at 1%) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2475185 | cellulase (Trichoderma longibrachiatum) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2475186 | monoethanolamine thioglycolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2475187 | Ginkgo biloba whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2475188 | carprofen 37.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2475189 | carprofen 37.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2475189 | carprofen 37.5 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2475190 | carprofen 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2475191 | carprofen 50 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2475191 | carprofen 50 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2475192 | pancreatic alpha-amylase | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2475193 | pancreatic triacylglycerol lipase | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2475195 | cabotegravir 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2475196 | cabotegravir Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2475196 | cabotegravir Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 2475196 | cabotegravir Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 2475197 | cabotegravir Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2475198 | cabotegravir Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2475199 | cabotegravir 30 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 2475199 | cabotegravir 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475199 | cabotegravir 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475199 | cabotegravir 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2475199 | cabotegravir 30 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 2475200 | Vocabria | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2475201 | cabotegravir 30 MG [Vocabria] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2475202 | cabotegravir Oral Tablet [Vocabria] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2475203 | Vocabria Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2475204 | Vocabria Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2475205 | VOCABRIA 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2475205 | VOCABRIA 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475205 | VOCABRIA 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475205 | VOCABRIA 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247522 | iodinated glycerol 12.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247531 | NaHCO3 460 MG/ML / tartaric acid 420 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247531 | NaHCO3 460 MG/ML / tartaric acid 420 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2475332 | sodium starch glycolate type B | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2475336 | norepinephrine 0.016 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2475337 | norepinephrine bitartrate 4 MG in 250 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2475337 | norepinephrine bitartrate 4 MG in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475337 | norepinephrine bitartrate 4 MG in 250 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475338 | norepinephrine 0.016 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2475339 | norepinephrine 0.032 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 247534 | magnesium gluconate 600 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2475340 | norepinephrine bitartrate 8 MG in 250 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2475340 | norepinephrine bitartrate 8 MG in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475340 | norepinephrine bitartrate 8 MG in 250 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475341 | norepinephrine 0.032 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2475349 | Bactine Wound Wash | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 247535 | magnesium gluconate 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2475350 | benzalkonium chloride 1.3 MG/ML [Bactine Wound Wash] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2475351 | benzalkonium Topical Solution [Bactine Wound Wash] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2475352 | Bactine Wound Wash Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2475353 | Bactine Wound Wash 0.13 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475353 | Bactine Wound Wash 0.13 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475353 | Bactine Wound Wash 0.13 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475353 | Bactine Wound Wash 0.13 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2475356 | menthol 10 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2475356 | menthol 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2475356 | menthol 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2475356 | menthol 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2475357 | menthol 0.1 MG/MG [Biofreeze] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2475358 | menthol Topical Ointment [Biofreeze] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2475359 | Biofreeze 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2475359 | Biofreeze 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2475359 | Biofreeze 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2475359 | Biofreeze 10 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2475360 | Lysosomal alpha-glucosidase | Designated preferred name (PT) | NO | |
RxCUI: 2475360 | Lysosomal alpha-glucosidase | Full form of descriptor (FN) | NO | |
RxCUI: 2475360 | Lysosomal alpha-glucosidase | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2475360 | Lysosomal alpha-glucosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2475361 | Alpha-glucosidase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2475361 | Alpha-glucosidase | Designated preferred name (PT) | NO | |
RxCUI: 2475361 | Alpha-glucosidase | Full form of descriptor (FN) | NO | |
RxCUI: 2475361 | Alpha-glucosidase | Designated preferred name (PT) | NO | |
RxCUI: 2475361 | Alpha-glucosidase | Full form of descriptor (FN) | NO | |
RxCUI: 247537 | allyl sulfide 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2475396 | voclosporin 7.9 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2475397 | voclosporin Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 2475397 | voclosporin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2475397 | voclosporin Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 2475398 | voclosporin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2475399 | voclosporin Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 247540 | sennosides, USP 244 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2475400 | voclosporin 7.9 MG Oral Capsule | Full form of descriptor (FN) | YES | |
RxCUI: 2475400 | voclosporin 7.9 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475400 | voclosporin 7.9 MG Oral Capsule | Designated preferred name (PT) | YES | |
RxCUI: 2475400 | voclosporin 7.9 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2475401 | Lupkynis | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2475402 | voclosporin 7.9 MG [Lupkynis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2475403 | voclosporin Oral Capsule [Lupkynis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2475404 | Lupkynis Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2475405 | Lupkynis Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2475406 | Lupkynis 7.9 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475406 | Lupkynis 7.9 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475406 | Lupkynis 7.9 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2475407 | cabotegravir 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2475408 | cabotegravir Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2475408 | cabotegravir Injectable Product | Designated preferred name (PT) | YES | |
RxCUI: 2475408 | cabotegravir Injectable Product | Full form of descriptor (FN) | YES | |
RxCUI: 2475411 | rilpivirine 300 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2475412 | rilpivirine Injectable Product | Full form of descriptor (FN) | YES | |
RxCUI: 2475412 | rilpivirine Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2475412 | rilpivirine Injectable Product | Designated preferred name (PT) | YES | |
RxCUI: 2475415 | cabotegravir 600 MG / rilpivirine 900 MG Extended Release Kit | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2475415 | cabotegravir 600 MG / rilpivirine 900 MG Extended Release Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475415 | cabotegravir 600 MG / rilpivirine 900 MG Extended Release Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475416 | CABENUVA 600 MG / 900 MG Extended Release Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2475416 | CABENUVA 600 MG / 900 MG Extended Release Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475416 | CABENUVA 600 MG / 900 MG Extended Release Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475417 | cabotegravir 400 MG / rilpivirine 600 MG Extended Release Kit | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2475417 | cabotegravir 400 MG / rilpivirine 600 MG Extended Release Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475417 | cabotegravir 400 MG / rilpivirine 600 MG Extended Release Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475418 | CABENUVA 400 MG / 600 MG Extended Release Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2475418 | CABENUVA 400 MG / 600 MG Extended Release Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475418 | CABENUVA 400 MG / 600 MG Extended Release Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247546 | allyl sulfide 341 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2475473 | menthol 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2475473 | menthol 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2475473 | menthol 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247549 | chromium picolinate 1.6 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247551 | budesonide 32 MCG/ACTUAT Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247551 | budesonide 32 MCG/ACTUAT Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247551 | budesonide 32 MCG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247551 | budesonide 32 MCG/ACTUAT Nasal Spray | Designated preferred name (PT) | NO | |
RxCUI: 247551 | budesonide 32 MCG/ACTUAT Nasal Spray | Full form of descriptor (FN) | NO | |
RxCUI: 2475532 | Abametapir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2475532 | Abametapir | Designated preferred name (PT) | YES | |
RxCUI: 2475532 | Abametapir | Full form of descriptor (FN) | YES | |
RxCUI: 2475532 | Abametapir | Designated preferred name (PT) | YES | |
RxCUI: 2475532 | Abametapir | Full form of descriptor (FN) | YES | |
RxCUI: 2475536 | abametapir 0.74 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475536 | abametapir 0.74 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475536 | abametapir 0.74 % Topical Lotion | Designated preferred name (PT) | YES | |
RxCUI: 2475536 | abametapir 0.74 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2475536 | abametapir 0.74 % Topical Lotion | Full form of descriptor (FN) | YES | |
RxCUI: 2475537 | Xeglyze | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2475540 | Xeglyze Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2475541 | Xeglyze 0.74 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2475541 | Xeglyze 0.74 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475541 | Xeglyze 0.74 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475541 | Xeglyze 0.74 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247557 | amylase 180000 UNT / lipase 22500 UNT / protease 180000 UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247558 | amylase 60000 UNT / lipase 12000 UNT / protease 60000 UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247577 | dyphylline 60 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247578 | phenolphthalein 0.0142 MG/MG Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247580 | mineral oil 0.78 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247581 | attapulgite 60 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247582 | kaolin 200 MG/ML / pectin 4.76 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247583 | dimenhyDRINATE 100 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247583 | dimenhyDRINATE 100 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247583 | dimenhyDRINATE 100 MG Rectal Suppository | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2475830 | vericiguat | Full form of descriptor (FN) | YES | |
RxCUI: 2475830 | vericiguat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2475830 | vericiguat | Designated preferred name (PT) | YES | |
RxCUI: 2475830 | vericiguat | Full form of descriptor (FN) | YES | |
RxCUI: 2475830 | vericiguat | Designated preferred name (PT) | YES | |
RxCUI: 2475835 | mannitol 40 MG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475835 | mannitol 40 MG Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2475836 | Bronchitol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2475839 | Bronchitol Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 247584 | dimenhyDRINATE 50 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247584 | dimenhyDRINATE 50 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247584 | dimenhyDRINATE 50 MG Rectal Suppository | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2475840 | Bronchitol 40 MG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475840 | Bronchitol 40 MG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475840 | Bronchitol 40 MG Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2475841 | ethanol 74 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2475841 | ethanol 74 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2475841 | ethanol 74 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2475842 | vericiguat 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2475843 | vericiguat Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 2475843 | vericiguat Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2475843 | vericiguat Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 2475844 | vericiguat Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2475845 | vericiguat Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2475846 | vericiguat 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 2475846 | vericiguat 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475846 | vericiguat 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 2475846 | vericiguat 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2475847 | Verquvo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2475848 | vericiguat 10 MG [Verquvo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2475849 | vericiguat Oral Tablet [Verquvo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 247585 | dimenhyDRINATE 25 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247585 | dimenhyDRINATE 25 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247585 | dimenhyDRINATE 25 MG Rectal Suppository | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2475850 | Verquvo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2475851 | Verquvo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2475852 | Verquvo 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2475852 | Verquvo 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475852 | Verquvo 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475853 | vericiguat 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2475854 | vericiguat 2.5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 2475854 | vericiguat 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475854 | vericiguat 2.5 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 2475854 | vericiguat 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2475855 | vericiguat 2.5 MG [Verquvo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2475856 | Verquvo 2.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2475856 | Verquvo 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475856 | Verquvo 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475857 | vericiguat 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2475858 | vericiguat 5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 2475858 | vericiguat 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475858 | vericiguat 5 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 2475858 | vericiguat 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2475859 | vericiguat 5 MG [Verquvo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2475860 | Verquvo 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2475860 | Verquvo 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475860 | Verquvo 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475861 | collagenase clostridium histolyticum-aaes | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2475862 | collagenase clostridium histolyticum-aaes 0.92 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2475863 | collagenase clostridium histolyticum-aaes 0.92 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475863 | collagenase clostridium histolyticum-aaes 0.92 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2475864 | Qwo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2475865 | collagenase clostridium histolyticum-aaes 0.92 MG [Qwo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2475866 | collagenase Clostridium histolyticum Injection [Qwo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2475867 | Qwo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2475868 | Qwo 0.92 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2475868 | Qwo 0.92 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475868 | Qwo 0.92 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2475869 | collagenase clostridium histolyticum-aaes 1.84 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2475870 | collagenase clostridium histolyticum-aaes 1.84 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475870 | collagenase clostridium histolyticum-aaes 1.84 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2475871 | collagenase clostridium histolyticum-aaes 1.84 MG [Qwo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2475872 | Qwo 1.84 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2475872 | Qwo 1.84 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2475872 | Qwo 1.84 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247588 | thioproperazine 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247589 | fluPHENAZine 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247589 | fluPHENAZine 2 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 24759 | Pentalenene synthase | Designated preferred name (PT) | NO | |
RxCUI: 24759 | Pentalenene synthase | Full form of descriptor (FN) | NO | |
RxCUI: 247593 | dimethyl sulfoxide 700 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2475947 | (2-carbethoxyethyl)triethoxysilane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2475951 | 2,3-dimercaptosuccinic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2475951 | 2,3-dimercaptosuccinic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2475952 | acetamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2475954 | palmitoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2475955 | palmitoleic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2475956 | Gluconic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2475956 | Gluconic acid | Designated preferred name (PT) | YES | |
RxCUI: 2475956 | Gluconic acid | Full form of descriptor (FN) | YES | |
RxCUI: 2475957 | potassium phosphate dibasic trihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2476004 | acetyl tetrapeptide-2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2476006 | N5-((2E)-((2-(((2,3-bis(omega-methoxypoly(oxyethylene))propoxy)carbonyl)amino)ethoxy)imino)ethyl)glutamine (43000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2476007 | polyglyceryl-3 methylglucose distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2476008 | Sulfachlorpyridazine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2476008 | Sulfachlorpyridazine | Designated preferred name (PT) | YES | |
RxCUI: 2476008 | Sulfachlorpyridazine | Full form of descriptor (FN) | YES | |
RxCUI: 2476008 | Sulfachlorpyridazine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
RxCUI: 2476009 | sulfachlorpyridazine sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2476018 | Vardenafil hydrochloride anhydrous | Designated preferred name (PT) | NO | |
RxCUI: 2476018 | Vardenafil hydrochloride anhydrous | Full form of descriptor (FN) | NO | |
RxCUI: 247617 | benzocaine 12 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247618 | cysteine 750 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247619 | leucine 600 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247620 | bismuth subsalicylate 262 MG / calcium carbonate 350 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247621 | idoxuridine 0.1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247621 | idoxuridine 0.1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247621 | idoxuridine 0.1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247626 | oxyCODONE 10 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247626 | oxyCODONE 10 MG Rectal Suppository | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 247627 | oxyCODONE 20 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247627 | oxyCODONE 20 MG Rectal Suppository | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 247630 | ketoprofen 50 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247630 | ketoprofen 50 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247636 | manganese gluconate 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247637 | hydroxocobalamin 0.05 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247638 | Fluorometholone 0.1 % / Neomycin 0.5 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247638 | Fluorometholone 0.1 % / Neomycin 0.5 % Ophthalmic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247646 | allyl sulfide 1250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247647 | Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 247647 | Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247647 | Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247647 | Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247647 | Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 247648 | chlorphenesin 10 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247649 | simethicone 160 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247650 | acetaminophen 160 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247650 | acetaminophen 160 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247650 | acetaminophen 160 MG Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247653 | APAP 325 MG / Meprobamate 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247653 | APAP 325 MG / Meprobamate 400 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247659 | flunarizine 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247661 | acetaminophen 80 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247661 | acetaminophen 80 MG in 1 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247661 | acetaminophen 80 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2476630 | 10-hydroxy-octadecanoic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2476630 | 10-hydroxy-octadecanoic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2476631 | ethyl hexanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2476631 | ethyl hexanoate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2476632 | Opuntia ficus indica leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2476636 | Sesquient | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2476637 | fosphenytoin sodium 75 MG/ML [Sesquient] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2476638 | fosphenytoin Injection [Sesquient] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2476639 | Sesquient Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2476640 | Sesquient 100 MG PE in 2 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2476640 | Sesquient 100 MG PE in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2476640 | Sesquient 100 MG PE in 2 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2476640 | Sesquient 100 MG PE in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2476641 | fosphenytoin sodium 75 MG/ML Injection [Sesquient] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2476641 | fosphenytoin sodium 75 MG/ML Injection [Sesquient] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2476642 | bismuth subsalicylate Chewable Tablet [Kaopectate Reformulated Aug 2006] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2476643 | Kaopectate Reformulated Aug 2006 Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2476644 | Kaopectate 262 MG Chewable Tablet, Reformulated Aug 2006 | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2476644 | Kaopectate 262 MG Chewable Tablet, Reformulated Aug 2006 | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2476644 | Kaopectate 262 MG Chewable Tablet, Reformulated Aug 2006 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247667 | potassium gluconate 2.5 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247667 | potassium gluconate 2.5 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247667 | potassium gluconate 2.5 MEQ Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 247667 | potassium gluconate 2.5 MEQ Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 247667 | potassium gluconate 2.5 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2476701 | Xylimelts | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2476702 | xylitol 550 MG [Xylimelts] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2476703 | xylitol Oral Lozenge [Xylimelts] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2476704 | Xylimelts Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2476705 | Xylimelts Lozenge Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2476706 | Xylimelts 550 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2476706 | Xylimelts 550 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2476706 | Xylimelts 550 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 247671 | germanium 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247673 | metroNIDAZOLE 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247673 | metroNIDAZOLE 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247673 | metroNIDAZOLE 500 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 247682 | salicylic acid 3 % / sulfur 5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247682 | salicylic acid 3 % / sulfur 5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247682 | salicylic acid 3 % / sulfur 5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247683 | sulfur 2.5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247683 | sulfur 2.5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247683 | sulfur 2.5 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247684 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 247684 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 247684 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247684 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247684 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247684 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247684 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 247684 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 247685 | sulfur 20.8 MG/ML Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247686 | tixocortol pivalate 2.5 MG/ML Enema | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247687 | erythromycin 0.04 MG/MG / tretinoin 0.0005 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247689 | formic acid 8 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247689 | formic acid 8 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247689 | formic acid 8 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247691 | budesonide 100 MCG/ACTUAT Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247691 | budesonide 100 MCG/ACTUAT Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247691 | budesonide 100 MCG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247691 | budesonide 100 MCG/ACTUAT Nasal Spray | Designated preferred name (PT) | NO | |
RxCUI: 247691 | budesonide 100 MCG/ACTUAT Nasal Spray | Full form of descriptor (FN) | NO | |
RxCUI: 247692 | phosphatidylcholine 3 GM per 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 247692 | phosphatidylcholine 3 GM per 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 247692 | phosphatidylcholine 3 GM per 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247694 | chlorophyll 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247694 | chlorophyll 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2476943 | cetylpyridinium chloride 0.05 % Mucosal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2476943 | cetylpyridinium chloride 0.05 % Mucosal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2476943 | cetylpyridinium chloride 0.05 % Mucosal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247705 | benzocaine 20 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247706 | benzocaine 100 MG/ML Oral Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477103 | tepotinib | Full form of descriptor (FN) | YES | |
RxCUI: 2477103 | tepotinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2477103 | tepotinib | Designated preferred name (PT) | YES | |
RxCUI: 2477103 | tepotinib | Full form of descriptor (FN) | YES | |
RxCUI: 2477103 | tepotinib | Designated preferred name (PT) | YES | |
RxCUI: 2477104 | tepotinib hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2477104 | tepotinib hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 2477104 | tepotinib hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 2477125 | Minocycline only product in cutaneous dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477125 | Minocycline only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477126 | Monomethyl fumarate only product | Designated preferred name (PT) | NO | |
RxCUI: 2477126 | Monomethyl fumarate only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477127 | Monomethyl fumarate only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477127 | Monomethyl fumarate only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477128 | Nelarabine only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477128 | Nelarabine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477129 | Nitric oxide only product in gas for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2477129 | Nitric oxide only product in gas for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2477130 | Product containing only selpercatinib (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477130 | Product containing only selpercatinib (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2477131 | Product containing only selpercatinib in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477131 | Product containing only selpercatinib in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2477132 | Product containing only somapacitan (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477132 | Product containing only somapacitan (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2477133 | Product containing only somapacitan in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477133 | Product containing only somapacitan in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2477134 | Arsenic trioxide only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477134 | Arsenic trioxide only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477135 | Atazanavir and ritonavir only product | Designated preferred name (PT) | NO | |
RxCUI: 2477135 | Atazanavir and ritonavir only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477136 | Atazanavir and ritonavir only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477136 | Atazanavir and ritonavir only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477137 | Nitrous oxide and oxygen only product | Designated preferred name (PT) | NO | |
RxCUI: 2477137 | Nitrous oxide and oxygen only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477138 | Nitrous oxide only product in gas for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2477138 | Nitrous oxide only product in gas for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2477139 | Oblimersen only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477139 | Oblimersen only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477140 | Ofatumumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477140 | Ofatumumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477141 | Olaparib only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477141 | Olaparib only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477142 | Oliceridine only product | Designated preferred name (PT) | NO | |
RxCUI: 2477142 | Oliceridine only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477143 | Oliceridine only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477143 | Oliceridine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477144 | Soya bean oil only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477144 | Soya bean oil only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477144 | Soya bean oil only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477145 | Soya bean oil refined only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477145 | Soya bean oil refined only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477145 | Soya bean oil refined only product | Designated preferred name (PT) | NO | |
RxCUI: 2477146 | Soya bean oil refined only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477146 | Soya bean oil refined only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477146 | Soya bean oil refined only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477147 | Pneumococcal 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477147 | Pneumococcal 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477147 | Pneumococcal 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2477147 | Pneumococcal 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2477150 | Atoltivimab and maftivimab and odesivimab only product | Designated preferred name (PT) | NO | |
RxCUI: 2477150 | Atoltivimab and maftivimab and odesivimab only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477151 | Atoltivimab and maftivimab and odesivimab only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477151 | Atoltivimab and maftivimab and odesivimab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477152 | Azacitidine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477152 | Azacitidine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477153 | Azacitidine only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477153 | Azacitidine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477154 | Bamlanivimab only product | Designated preferred name (PT) | NO | |
RxCUI: 2477154 | Bamlanivimab only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477155 | Bamlanivimab only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477155 | Bamlanivimab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477156 | Bazedoxifene only product | Designated preferred name (PT) | NO | |
RxCUI: 2477156 | Bazedoxifene only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477157 | Bazedoxifene only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477157 | Bazedoxifene only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477158 | Belantamab mafodotin only product | Designated preferred name (PT) | NO | |
RxCUI: 2477158 | Belantamab mafodotin only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477159 | Belantamab mafodotin only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477159 | Belantamab mafodotin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477161 | Oxybuprocaine only product in ocular dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477161 | Oxybuprocaine only product in ocular dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477161 | Oxybuprocaine only product in ocular dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477162 | Bilastine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477162 | Bilastine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477163 | Bilastine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477163 | Bilastine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477164 | Bortezomib only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477164 | Bortezomib only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477165 | Brentuximab vedotin only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477165 | Brentuximab vedotin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477166 | Brexucabtagene autoleucel only product | Designated preferred name (PT) | NO | |
RxCUI: 2477166 | Brexucabtagene autoleucel only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477167 | Brexucabtagene autoleucel only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477167 | Brexucabtagene autoleucel only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477168 | Product containing only tafasitamab (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477168 | Product containing only tafasitamab (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2477169 | Product containing only tafasitamab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477169 | Product containing only tafasitamab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 247717 | folate 1 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247717 | folate 1 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477170 | Product containing only trastuzumab emtansine (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477170 | Product containing only trastuzumab emtansine (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2477171 | Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477171 | Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2477172 | Calcium carbonate only product in cutaneous dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477172 | Calcium carbonate only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477173 | Calcium oxybate and magnesium oxybate and potassium oxybate and sodium oxybate only product | Designated preferred name (PT) | NO | |
RxCUI: 2477173 | Calcium oxybate and magnesium oxybate and potassium oxybate and sodium oxybate only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477174 | Calcium oxybate and magnesium oxybate and potassium oxybate and sodium oxybate only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477174 | Calcium oxybate and magnesium oxybate and potassium oxybate and sodium oxybate only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477175 | Canakinumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477175 | Canakinumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477176 | Capmatinib only product | Designated preferred name (PT) | NO | |
RxCUI: 2477176 | Capmatinib only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477177 | Capmatinib only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477177 | Capmatinib only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477178 | Product containing only triheptanoin (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477178 | Product containing only triheptanoin (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2477179 | Product containing only triheptanoin in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477179 | Product containing only triheptanoin in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 247718 | polysaccharide iron complex 1.11 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477180 | Carbon (13-C) urea only product | Designated preferred name (PT) | NO | |
RxCUI: 2477180 | Carbon (13-C) urea only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477181 | Carbon (13-C) urea only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477181 | Carbon (13-C) urea only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477182 | Carbon dioxide and oxygen only product | Designated preferred name (PT) | NO | |
RxCUI: 2477182 | Carbon dioxide and oxygen only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477183 | Carbon dioxide only product | Designated preferred name (PT) | NO | |
RxCUI: 2477183 | Carbon dioxide only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477184 | Cedazuridine and decitabine only product | Designated preferred name (PT) | NO | |
RxCUI: 2477184 | Cedazuridine and decitabine only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477185 | Cedazuridine and decitabine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477185 | Cedazuridine and decitabine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477186 | Chondroitin only product | Designated preferred name (PT) | NO | |
RxCUI: 2477186 | Chondroitin only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477187 | Product containing only valrubicin in intravesical dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477187 | Product containing only valrubicin in intravesical dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2477188 | Product containing only vandetanib in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477188 | Product containing only vandetanib in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2477189 | Product containing only viltolarsen (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477189 | Product containing only viltolarsen (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 247719 | FESO4 45 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247719 | FESO4 45 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477190 | Product containing only viltolarsen in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477190 | Product containing only viltolarsen in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2477191 | Product containing only vinflunine (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477191 | Product containing only vinflunine (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2477192 | Product containing only vinflunine in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477192 | Product containing only vinflunine in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2477193 | Product containing only wool alcohol in ocular dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477193 | Product containing only wool alcohol in ocular dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2477194 | Clascoterone only product | Designated preferred name (PT) | NO | |
RxCUI: 2477194 | Clascoterone only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477195 | Clascoterone only product in cutaneous dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477195 | Clascoterone only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477196 | Coagulation factor V only product | Designated preferred name (PT) | NO | |
RxCUI: 2477196 | Coagulation factor V only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477197 | Coagulation factor VII only product | Designated preferred name (PT) | NO | |
RxCUI: 2477197 | Coagulation factor VII only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477198 | Copper (64-Cu) dotatate only product | Designated preferred name (PT) | NO | |
RxCUI: 2477198 | Copper (64-Cu) dotatate only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477199 | Copper (64-Cu) dotatate only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477199 | Copper (64-Cu) dotatate only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 247720 | edoxudine 30 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477200 | Cyclizine and morphine only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477200 | Cyclizine and morphine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477201 | Dimeticone and loperamide only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477201 | Dimeticone and loperamide only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477201 | Dimeticone and loperamide only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477202 | Dulaglutide only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477202 | Dulaglutide only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477203 | Hydroxyapatite only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477203 | Hydroxyapatite only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477203 | Hydroxyapatite only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477204 | Efavirenz and lamivudine and tenofovir only product | Designated preferred name (PT) | NO | |
RxCUI: 2477204 | Efavirenz and lamivudine and tenofovir only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477205 | Efavirenz and lamivudine and tenofovir only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477205 | Efavirenz and lamivudine and tenofovir only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477206 | Elagolix and estradiol and norethisterone only product | Designated preferred name (PT) | NO | |
RxCUI: 2477206 | Elagolix and estradiol and norethisterone only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477206 | Elagolix and estradiol and norethisterone only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477207 | Elagolix and estradiol and norethisterone only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477207 | Elagolix and estradiol and norethisterone only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477207 | Elagolix and estradiol and norethisterone only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477208 | Pertuzumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477208 | Pertuzumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477209 | Fenfluramine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477209 | Fenfluramine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477210 | Flortaucipir (18-F) only product | Designated preferred name (PT) | NO | |
RxCUI: 2477210 | Flortaucipir (18-F) only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477211 | Flortaucipir (18-F) only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477211 | Flortaucipir (18-F) only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477212 | Polyestradiol only product | Designated preferred name (PT) | NO | |
RxCUI: 2477212 | Polyestradiol only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477213 | Polystyrene sulfonate only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477213 | Polystyrene sulfonate only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477214 | Polystyrene sulfonate only product in rectal dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477214 | Polystyrene sulfonate only product in rectal dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477215 | Porcine insulin soluble and porcine isophane insulin only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477215 | Porcine insulin soluble and porcine isophane insulin only product | Designated preferred name (PT) | NO | |
RxCUI: 2477215 | Porcine insulin soluble and porcine isophane insulin only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477216 | Porcine insulin soluble and porcine isophane insulin only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477216 | Porcine insulin soluble and porcine isophane insulin only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477216 | Porcine insulin soluble and porcine isophane insulin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477217 | Porcine isophane insulin only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477217 | Porcine isophane insulin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477218 | Fluoroestradiol (18-F) only product | Designated preferred name (PT) | NO | |
RxCUI: 2477218 | Fluoroestradiol (18-F) only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477219 | Fluoroestradiol (18-F) only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477219 | Fluoroestradiol (18-F) only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477220 | Fostemsavir only product | Designated preferred name (PT) | NO | |
RxCUI: 2477220 | Fostemsavir only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477221 | Fostemsavir only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477221 | Fostemsavir only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477222 | Haemophilus influenzae type b and meningitis C and Y vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477222 | Haemophilus influenzae type b and meningitis C and Y vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2477222 | Haemophilus influenzae type b and meningitis C and Y vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2477223 | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2477223 | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477223 | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2477224 | Pralatrexate only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477224 | Pralatrexate only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477225 | Pralsetinib only product | Designated preferred name (PT) | NO | |
RxCUI: 2477225 | Pralsetinib only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477226 | Pralsetinib only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477226 | Pralsetinib only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477227 | Helium and nitrogen and oxygen only product | Designated preferred name (PT) | NO | |
RxCUI: 2477227 | Helium and nitrogen and oxygen only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477228 | Helium and nitrogen and oxygen only product in gas for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2477228 | Helium and nitrogen and oxygen only product in gas for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2477229 | Helium and oxygen only product | Designated preferred name (PT) | NO | |
RxCUI: 2477229 | Helium and oxygen only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477230 | Human isophane insulin and recombinant human soluble insulin only product | Designated preferred name (PT) | NO | |
RxCUI: 2477230 | Human isophane insulin and recombinant human soluble insulin only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477230 | Human isophane insulin and recombinant human soluble insulin only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477231 | Human isophane insulin and recombinant human soluble insulin only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477231 | Human isophane insulin and recombinant human soluble insulin only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477231 | Human isophane insulin and recombinant human soluble insulin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477232 | Human isophane insulin only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477232 | Human isophane insulin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477233 | Idelalisib only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477233 | Idelalisib only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477234 | Inactivated whole Hepatitis A GBM strain vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477234 | Inactivated whole Hepatitis A GBM strain vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2477234 | Inactivated whole Hepatitis A GBM strain vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2477235 | Inactivated whole Hepatitis A HM-175 strain vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477235 | Inactivated whole Hepatitis A HM-175 strain vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2477235 | Inactivated whole Hepatitis A HM-175 strain vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2477236 | Inactivated whole Influenza H5N1 vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2477236 | Inactivated whole Influenza H5N1 vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477236 | Inactivated whole Influenza H5N1 vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2477237 | Abametapir only product | Designated preferred name (PT) | NO | |
RxCUI: 2477237 | Abametapir only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477238 | Abametapir only product in cutaneous dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477238 | Abametapir only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477239 | Inebilizumab only product | Designated preferred name (PT) | NO | |
RxCUI: 2477239 | Inebilizumab only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477240 | Inebilizumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477240 | Inebilizumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477241 | Influenza H5N1 vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2477241 | Influenza H5N1 vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477241 | Influenza H5N1 vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2477242 | Insulin lispro and insulin lispro protamine only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477242 | Insulin lispro and insulin lispro protamine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477243 | Live attenuated Oka strain varicella vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2477243 | Live attenuated Oka strain varicella vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477243 | Live attenuated Oka strain varicella vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2477244 | Live attenuated Oka-Merck strain varicella vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2477244 | Live attenuated Oka-Merck strain varicella vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477244 | Live attenuated Oka-Merck strain varicella vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2477245 | Live attenuated influenza vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477245 | Live attenuated influenza vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2477245 | Live attenuated influenza vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2477246 | Agomelatine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477246 | Agomelatine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477247 | Air and carbon dioxide only product | Designated preferred name (PT) | NO | |
RxCUI: 2477247 | Air and carbon dioxide only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477248 | Air and carbon dioxide only product in gas for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2477248 | Air and carbon dioxide only product in gas for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2477249 | Tdap - Low dose diphtheria and low dose acellular pertussis and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2477249 | Tdap - Low dose diphtheria and low dose acellular pertussis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477249 | Tdap - Low dose diphtheria and low dose acellular pertussis and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2477250 | Lurbinectedin only product | Designated preferred name (PT) | NO | |
RxCUI: 2477250 | Lurbinectedin only product | Full form of descriptor (FN) | NO | |
RxCUI: 2477251 | Lurbinectedin only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477251 | Lurbinectedin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477252 | Phenazone only product in otic dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477252 | Phenazone only product in otic dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477252 | Phenazone only product in otic dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477253 | Product containing only remimazolam (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477253 | Product containing only remimazolam (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2477254 | Product containing only remimazolam in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477254 | Product containing only remimazolam in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2477255 | Product containing only rimegepant in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477255 | Product containing only rimegepant in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2477256 | Product containing only ripretinib (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477256 | Product containing only ripretinib (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2477257 | Product containing only ripretinib in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477257 | Product containing only ripretinib in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2477258 | Product containing only risdiplam (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477258 | Product containing only risdiplam (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2477259 | Product containing only risdiplam in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477259 | Product containing only risdiplam in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 247726 | hydrocortisone 0.01 MG/MG / neomycin 0.005 MG/MG Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477260 | Product containing only satralizumab (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477260 | Product containing only satralizumab (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2477261 | Product containing only satralizumab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477261 | Product containing only satralizumab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2477262 | tepotinib 225 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2477263 | tepotinib Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 2477263 | tepotinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2477263 | tepotinib Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 2477264 | tepotinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2477265 | tepotinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2477266 | tepotinib 225 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 2477266 | tepotinib 225 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 2477266 | tepotinib 225 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2477266 | tepotinib 225 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2477266 | tepotinib 225 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2477267 | Tepmetko | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2477268 | tepotinib 225 MG [Tepmetko] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2477269 | tepotinib Oral Tablet [Tepmetko] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2477270 | Tepmetko Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2477271 | Tepmetko Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2477272 | TEPMETKO 225 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2477272 | TEPMETKO 225 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2477272 | TEPMETKO 225 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2477272 | TEPMETKO 225 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2477274 | Acetylcholine-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477274 | Acetylcholine-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477275 | Adrenergic receptor antagonist-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477275 | Adrenergic receptor antagonist-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477276 | Air- and carbon dioxide-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477276 | Air- and carbon dioxide-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477277 | Artemisinin-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477277 | Artemisinin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477278 | Air- and carbon dioxide-containing product in gas for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2477278 | Air- and carbon dioxide-containing product in gas for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2477279 | Artenimol-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477279 | Artenimol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 247728 | calcium carbonate 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477280 | Alpha-adrenergic and beta-adrenergic agonist-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477280 | Alpha-adrenergic and beta-adrenergic agonist-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477281 | Artenimol-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477281 | Artenimol-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477282 | Atazanavir- and ritonavir-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477282 | Atazanavir- and ritonavir-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477283 | Oxybuprocaine-containing product in ocular dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477283 | Oxybuprocaine-containing product in ocular dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477283 | Oxybuprocaine-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477284 | Bilastine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477284 | Bilastine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477285 | Calcium carbonate-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477285 | Calcium carbonate-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477286 | Chondroitin-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477286 | Chondroitin-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477287 | Coagulation factor V-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477287 | Coagulation factor V-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477288 | petrolatum 459 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2477289 | benzocaine 10 % / petrolatum 45.9 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2477289 | benzocaine 10 % / petrolatum 45.9 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477289 | benzocaine 10 % / petrolatum 45.9 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477290 | Calcium oxybate- and magnesium oxybate- and potassium oxybate- and sodium oxybate-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477290 | Calcium oxybate- and magnesium oxybate- and potassium oxybate- and sodium oxybate-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477291 | Coagulation factor-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477291 | Coagulation factor-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477291 | Coagulation factor-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477291 | Coagulation factor-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477292 | Copper (64-Cu) dotatate-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477292 | Copper (64-Cu) dotatate-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477293 | Copper-62-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477293 | Copper-62-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477295 | Flortaucipir (18-F)-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477295 | Flortaucipir (18-F)-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477296 | Fluoroestradiol (18-F)-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477296 | Fluoroestradiol (18-F)-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477297 | Genetically modified virus-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477297 | Genetically modified virus-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477299 | chlorhexidine gluconate 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 247730 | calcium gluconate 5.8 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477300 | chlorhexidine gluconate 2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477300 | chlorhexidine gluconate 2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2477300 | chlorhexidine gluconate 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477301 | Mineral-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477301 | Mineral-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477302 | Nitrous oxide- and oxygen-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477302 | Nitrous oxide- and oxygen-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477303 | Nitrous oxide- and oxygen-containing product in gas for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2477303 | Nitrous oxide- and oxygen-containing product in gas for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2477304 | Oblimersen-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477304 | Oblimersen-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477305 | Oxyquinoline structure-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477305 | Oxyquinoline structure-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477307 | Penicillin-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477307 | Penicillin-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477309 | Piperaquine-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477309 | Piperaquine-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 247731 | manganese gluconate 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477310 | Bilastine 10 mg orodispersible tablet | Designated preferred name (PT) | NO | |
RxCUI: 2477310 | Bilastine 10 mg orodispersible tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2477311 | Plasma protein-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477311 | Plasma protein-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477312 | Podophyllotoxin and/or podophyllotoxin derivative-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477312 | Podophyllotoxin and/or podophyllotoxin derivative-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477313 | Product containing precisely secukinumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2477313 | Product containing precisely secukinumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2477314 | Nitrous oxide 50% and oxygen 50% gas for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2477314 | Nitrous oxide 50% and oxygen 50% gas for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477314 | Nitrous oxide 50% and oxygen 50% gas for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477314 | Nitrous oxide 50% and oxygen 50% gas for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2477315 | Polystyrene sulfonate-containing product in rectal dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477315 | Polystyrene sulfonate-containing product in rectal dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477316 | Recombinant DNA-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477316 | Recombinant DNA-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477316 | Recombinant DNA-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477317 | Product containing recombinant interleukin 2 (product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477317 | Product containing recombinant interleukin 2 (product) | Designated preferred name (PT) | NO | |
RxCUI: 2477318 | Product containing selective progesterone receptor modulator (product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477318 | Product containing selective progesterone receptor modulator (product) | Designated preferred name (PT) | NO | |
RxCUI: 2477319 | Product containing somapacitan (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477319 | Product containing somapacitan (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 247732 | manganese gluconate 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477321 | Soya bean oil refined-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2477321 | Soya bean oil refined-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477321 | Soya bean oil refined-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2477322 | Soya bean oil refined-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477322 | Soya bean oil refined-containing product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477322 | Soya bean oil refined-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477323 | Product containing trastuzumab emtansine in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477323 | Product containing trastuzumab emtansine in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2477324 | Medicinal product containing Vinca alkaloid and acting as antineoplastic agent (product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477324 | Medicinal product containing Vinca alkaloid and acting as antineoplastic agent (product) | Designated preferred name (PT) | NO | |
RxCUI: 2477325 | Product containing vinflunine (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477325 | Product containing vinflunine (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2477326 | Product containing vinflunine in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477326 | Product containing vinflunine in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2477327 | Product containing wool alcohol in ocular dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2477327 | Product containing wool alcohol in ocular dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 247733 | Monobasic Pot phosphate 176 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247733 | Monobasic Pot phosphate 176 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247733 | Monobasic Pot phosphate 176 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247734 | K+ Chloride 12 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247734 | K+ Chloride 12 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247734 | K+ Chloride 12 MEQ Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247738 | ZnSO4 1.35 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247738 | ZnSO4 1.35 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247741 | choline 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247742 | inositol 400 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247743 | piperacetazine 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477431 | antimony trioxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 247744 | dichloralphenazone 650 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247745 | sodium salicylate 570 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247747 | niacin 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 247747 | niacin 500 MG Oral Capsule | Designated preferred name (PT) | YES | |
RxCUI: 247747 | niacin 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 247747 | niacin 500 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247747 | niacin 500 MG Oral Capsule | Full form of descriptor (FN) | YES | |
RxCUI: 247747 | niacin 500 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247747 | niacin 500 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247748 | pantothenic acid 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247749 | vitamin C 850 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247749 | vitamin C 850 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247749 | vitamin C 850 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247750 | ascorbic acid 400 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247750 | ascorbic acid 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247750 | ascorbic acid 400 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247750 | ascorbic acid 400 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247751 | vit-C 550 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247751 | vit-C 550 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247751 | vit-C 550 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247752 | beta carotene 2000 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477530 | hydrogen peroxide 0.0214 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2477531 | hydrogen peroxide Oral Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2477532 | hydrogen peroxide Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2477533 | hydrogen peroxide Toothpaste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2477534 | hydrogen peroxide Toothpaste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2477535 | hydrogen peroxide 2.14 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477535 | hydrogen peroxide 2.14 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2477535 | hydrogen peroxide 2.14 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477536 | camphor 5 % / methyl salicylate 50 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2477536 | camphor 5 % / methyl salicylate 50 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477536 | camphor 5 % / methyl salicylate 50 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477549 | Metoprolol tartrate 1 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2477549 | Metoprolol tartrate 1 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 247755 | ethanol 2 ML/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477559 | Medicinal product containing sulfonamide and acting as diuretic agent (product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477559 | Medicinal product containing sulfonamide and acting as diuretic agent (product) | Designated preferred name (PT) | NO | |
RxCUI: 2477563 | Substance with tetracyclic structure | Designated preferred name (PT) | NO | |
RxCUI: 2477563 | Substance with tetracyclic structure | Full form of descriptor (FN) | NO | |
RxCUI: 2477568 | Varenicline dihydrochloride | Designated preferred name (PT) | NO | |
RxCUI: 2477568 | Varenicline dihydrochloride | Full form of descriptor (FN) | NO | |
RxCUI: 247757 | calcium ascorbate 250 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477573 | Lapatinib ditosylate monohydrate | Designated preferred name (PT) | NO | |
RxCUI: 2477573 | Lapatinib ditosylate monohydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2477574 | Halofuginone hydrobromide | Designated preferred name (PT) | NO | |
RxCUI: 2477574 | Halofuginone hydrobromide | Full form of descriptor (FN) | NO | |
RxCUI: 2477576 | Selective progesterone receptor modulator | Designated preferred name (PT) | NO | |
RxCUI: 2477576 | Selective progesterone receptor modulator | Full form of descriptor (FN) | NO | |
RxCUI: 2477577 | Recombinant interleukin 2 | Designated preferred name (PT) | NO | |
RxCUI: 2477577 | Recombinant interleukin 2 | Full form of descriptor (FN) | NO | |
RxCUI: 247758 | calcium ascorbate 550 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477580 | Recombinant coagulation factor VIII | Designated preferred name (PT) | NO | |
RxCUI: 2477580 | Recombinant coagulation factor VIII | Full form of descriptor (FN) | NO | |
RxCUI: 2477581 | Recombinant coagulation factor VII | Designated preferred name (PT) | NO | |
RxCUI: 2477581 | Recombinant coagulation factor VII | Full form of descriptor (FN) | NO | |
RxCUI: 2477583 | Medicinal product containing purine and/or purine derivative and acting as diuretic agent (product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477583 | Medicinal product containing purine and/or purine derivative and acting as diuretic agent (product) | Designated preferred name (PT) | NO | |
RxCUI: 2477589 | Hydroxocobalamin chloride | Designated preferred name (PT) | NO | |
RxCUI: 2477589 | Hydroxocobalamin chloride | Full form of descriptor (FN) | NO | |
RxCUI: 247759 | flumethasone 0.0002 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477590 | Semduramicin sodium | Designated preferred name (PT) | NO | |
RxCUI: 2477590 | Semduramicin sodium | Full form of descriptor (FN) | NO | |
RxCUI: 2477591 | Messenger ribonucleic acid of 2019-nCoV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477591 | Messenger ribonucleic acid of 2019-nCoV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477591 | Messenger ribonucleic acid of 2019-nCoV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477591 | Messenger ribonucleic acid of 2019-nCoV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477591 | Messenger ribonucleic acid of 2019-nCoV | Full form of descriptor (FN) | NO | |
RxCUI: 2477591 | Messenger ribonucleic acid of 2019-nCoV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477591 | Messenger ribonucleic acid of 2019-nCoV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477591 | Messenger ribonucleic acid of 2019-nCoV | Designated preferred name (PT) | NO | |
RxCUI: 2477592 | Oxazolidinone | Designated preferred name (PT) | NO | |
RxCUI: 2477592 | Oxazolidinone | Full form of descriptor (FN) | NO | |
RxCUI: 2477593 | Substance with adrenergic receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
RxCUI: 2477593 | Substance with adrenergic receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
RxCUI: 2477594 | Beta-lactamase inhibitor antibacterial agent | Designated preferred name (PT) | NO | |
RxCUI: 2477594 | Beta-lactamase inhibitor antibacterial agent | Full form of descriptor (FN) | NO | |
RxCUI: 2477595 | Bialamicol | Designated preferred name (PT) | NO | |
RxCUI: 2477595 | Bialamicol | Full form of descriptor (FN) | NO | |
RxCUI: 2477597 | Thiazide | Designated preferred name (PT) | NO | |
RxCUI: 2477597 | Thiazide | Full form of descriptor (FN) | NO | |
RxCUI: 2477599 | Triazene | Designated preferred name (PT) | NO | |
RxCUI: 2477599 | Triazene | Full form of descriptor (FN) | NO | |
RxCUI: 247760 | urea 50 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247760 | urea 50 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247760 | urea 50 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247760 | urea 50 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477600 | Medicinal product containing triazene and acting as antineoplastic agent (product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477600 | Medicinal product containing triazene and acting as antineoplastic agent (product) | Designated preferred name (PT) | NO | |
RxCUI: 2477602 | Trifluridine hydrochloride | Designated preferred name (PT) | NO | |
RxCUI: 2477602 | Trifluridine hydrochloride | Full form of descriptor (FN) | NO | |
RxCUI: 2477604 | Perindopril erbumine monohydrate | Designated preferred name (PT) | NO | |
RxCUI: 2477604 | Perindopril erbumine monohydrate | Full form of descriptor (FN) | NO | |
RxCUI: 247762 | lactic acid 0.04 MG/MG / salicylic acid 0.11 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477635 | Bilastine 2.5 mg/mL oral solution | Designated preferred name (PT) | NO | |
RxCUI: 2477635 | Bilastine 2.5 mg/mL oral solution | Full form of descriptor (FN) | NO | |
RxCUI: 2477636 | Bilastine 20 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2477636 | Bilastine 20 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2477637 | melatonin 1 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2477637 | melatonin 1 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2477638 | Bilastine-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477638 | Bilastine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477639 | Miltefosine 10 mg oral capsule | Designated preferred name (PT) | NO | |
RxCUI: 2477639 | Miltefosine 10 mg oral capsule | Full form of descriptor (FN) | NO | |
RxCUI: 2477640 | Mifepristone 600 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2477640 | Mifepristone 600 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2477641 | Misoprostol 400 microgram oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2477641 | Misoprostol 400 microgram oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2477642 | Nevirapine 50 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2477642 | Nevirapine 50 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2477643 | Atazanavir (as atazanavir sulfate) 300 mg and ritonavir 100 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2477643 | Atazanavir (as atazanavir sulfate) 300 mg and ritonavir 100 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2477644 | Atazanavir- and ritonavir-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477644 | Atazanavir- and ritonavir-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477645 | Azilsartan medoxomil (as azilsartan medoxomil potassium) 20 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2477645 | Azilsartan medoxomil (as azilsartan medoxomil potassium) 20 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2477647 | Bazedoxifene (as bazedoxifene acetate) 20 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2477647 | Bazedoxifene (as bazedoxifene acetate) 20 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2477648 | Bazedoxifene-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477648 | Bazedoxifene-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477649 | Mepolizumab 100 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2477649 | Mepolizumab 100 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 247765 | diphtheria toxoid vaccine, inactivated 50 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477650 | Luspatercept 75 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2477650 | Luspatercept 75 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2477652 | Calcium polystyrene sulfonate 999.34 mg/g powder for oral or rectal suspension | Designated preferred name (PT) | NO | |
RxCUI: 2477652 | Calcium polystyrene sulfonate 999.34 mg/g powder for oral or rectal suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2477653 | Luspatercept 25 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2477653 | Luspatercept 25 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2477654 | Capecitabine 300 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2477654 | Capecitabine 300 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2477655 | Adalimumab 100 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2477655 | Adalimumab 100 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2477656 | Product containing precisely triclabendazole 50 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2477656 | Product containing precisely triclabendazole 50 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2477657 | Ixekizumab 80 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2477657 | Ixekizumab 80 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2477658 | Inebilizumab 10 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2477658 | Inebilizumab 10 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2477659 | Product containing precisely triheptanoin 960 milligram/1 milliliter conventional release oral solution (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2477659 | Product containing precisely triheptanoin 960 milligram/1 milliliter conventional release oral solution (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 247766 | diphtheria toxoid vaccine, inactivated 0.2 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477660 | Perindopril arginine 5 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2477660 | Perindopril arginine 5 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2477661 | Piperaquine-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477661 | Piperaquine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477662 | Fluoroestradiol (18-F) 100 mCi/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2477662 | Fluoroestradiol (18-F) 100 mCi/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2477663 | Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477663 | Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2477663 | Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2477665 | Adrenaline 500 microgram/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477665 | Adrenaline 500 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2477665 | Adrenaline 500 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2477666 | Paracetamol 500 mg tablet for oral solution | Designated preferred name (PT) | NO | |
RxCUI: 2477666 | Paracetamol 500 mg tablet for oral solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477666 | Paracetamol 500 mg tablet for oral solution | Full form of descriptor (FN) | NO | |
RxCUI: 2477667 | Acetylcysteine 600 mg effervescent oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2477667 | Acetylcysteine 600 mg effervescent oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2477668 | Afatinib (as afatinib dimaleate) 50 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2477668 | Afatinib (as afatinib dimaleate) 50 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2477669 | Agomelatine (as agomelatine citric acid) 25 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2477669 | Agomelatine (as agomelatine citric acid) 25 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2477670 | Agomelatine 25 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2477670 | Agomelatine 25 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2477671 | Agomelatine-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2477671 | Agomelatine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2477673 | Burosumab 10 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2477673 | Burosumab 10 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2477674 | Burosumab 20 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2477674 | Burosumab 20 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2477675 | Burosumab 30 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2477675 | Burosumab 30 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2477676 | Calcium carbonate 900 mg/g cutaneous powder | Designated preferred name (PT) | NO | |
RxCUI: 2477676 | Calcium carbonate 900 mg/g cutaneous powder | Full form of descriptor (FN) | NO | |
RxCUI: 2477678 | Product containing precisely pyrazinamide 400 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2477678 | Product containing precisely pyrazinamide 400 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2477679 | Product containing precisely wool alcohol 2 milligram/1 gram conventional release eye ointment (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2477679 | Product containing precisely wool alcohol 2 milligram/1 gram conventional release eye ointment (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2477680 | pramoxine HCl 0.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2477680 | pramoxine HCl 0.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477680 | pramoxine HCl 0.5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477681 | Product containing precisely pyridoxine hydrochloride 40 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2477681 | Product containing precisely pyridoxine hydrochloride 40 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2477682 | Air 95% and carbon dioxide 5% gas for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2477682 | Air 95% and carbon dioxide 5% gas for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477682 | Air 95% and carbon dioxide 5% gas for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477682 | Air 95% and carbon dioxide 5% gas for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2477683 | Abacavir (as abacavir sulfate) 60 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2477683 | Abacavir (as abacavir sulfate) 60 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477683 | Abacavir (as abacavir sulfate) 60 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2477684 | Potassium chloride 75 mg/mL oral solution | Designated preferred name (PT) | NO | |
RxCUI: 2477684 | Potassium chloride 75 mg/mL oral solution | Full form of descriptor (FN) | NO | |
RxCUI: 2477685 | Dupilumab 150 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2477685 | Dupilumab 150 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 247769 | Rho(D) immune globulin 0.096 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477692 | Nitric oxide 980 nanogram/mL gas for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2477692 | Nitric oxide 980 nanogram/mL gas for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2477706 | Prednisolone (as prednisolone metasulfobenzoate sodium) 20 mg/actuation rectal foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477706 | Prednisolone (as prednisolone metasulfobenzoate sodium) 20 mg/actuation rectal foam | Designated preferred name (PT) | NO | |
RxCUI: 2477706 | Prednisolone (as prednisolone metasulfobenzoate sodium) 20 mg/actuation rectal foam | Full form of descriptor (FN) | NO | |
RxCUI: 2477707 | Hydroxocobalamin (as hydroxocobalamin chloride) 1 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2477707 | Hydroxocobalamin (as hydroxocobalamin chloride) 1 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 247777 | lidocaine 100 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247778 | calcium alginate 810 MG/ML Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247782 | triclosan 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247782 | triclosan 1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247783 | triclosan 0.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247783 | triclosan 0.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247783 | triclosan 0.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247784 | triclosan 0.0075 MG/MG Medicated Bar Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247785 | triclosan 20 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477850 | Laccocephalum mylittae whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2477851 | Areca catechu fruit rind extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2477852 | cifostodine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2477853 | Cleome gynandra whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2477854 | etesevimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2477854 | etesevimab | Designated preferred name (PT) | YES | |
RxCUI: 2477854 | etesevimab | Full form of descriptor (FN) | YES | |
RxCUI: 2477855 | Agomelatine citric acid | Designated preferred name (PT) | NO | |
RxCUI: 2477855 | Agomelatine citric acid | Full form of descriptor (FN) | NO | |
RxCUI: 2477856 | Aldosterone receptor antagonist diuretic agent | Designated preferred name (PT) | NO | |
RxCUI: 2477856 | Aldosterone receptor antagonist diuretic agent | Full form of descriptor (FN) | NO | |
RxCUI: 2477857 | Alpha-adrenergic and beta-adrenergic agonist | Designated preferred name (PT) | NO | |
RxCUI: 2477857 | Alpha-adrenergic and beta-adrenergic agonist | Full form of descriptor (FN) | NO | |
RxCUI: 247786 | triclosan 0.003 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477860 | Thiacetarsamide sodium | Designated preferred name (PT) | NO | |
RxCUI: 2477860 | Thiacetarsamide sodium | Full form of descriptor (FN) | NO | |
RxCUI: 2477860 | Thiacetarsamide sodium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477861 | Azilsartan medoxomil potassium | Designated preferred name (PT) | NO | |
RxCUI: 2477861 | Azilsartan medoxomil potassium | Full form of descriptor (FN) | NO | |
RxCUI: 2477863 | Cyclic lipopeptide | Designated preferred name (PT) | NO | |
RxCUI: 2477863 | Cyclic lipopeptide | Full form of descriptor (FN) | NO | |
RxCUI: 2477865 | COVID-19 antigen vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477865 | COVID-19 antigen vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477865 | COVID-19 antigen vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2477865 | COVID-19 antigen vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477865 | COVID-19 antigen vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2477866 | Purine and/or purine derivative | Designated preferred name (PT) | NO | |
RxCUI: 2477866 | Purine and/or purine derivative | Full form of descriptor (FN) | NO | |
RxCUI: 2477867 | Podophyllotoxin and/or podophyllotoxin derivative | Designated preferred name (PT) | NO | |
RxCUI: 2477867 | Podophyllotoxin and/or podophyllotoxin derivative | Full form of descriptor (FN) | NO | |
RxCUI: 2477868 | Plant sesquiterpene lactone | Designated preferred name (PT) | NO | |
RxCUI: 2477868 | Plant sesquiterpene lactone | Full form of descriptor (FN) | NO | |
RxCUI: 247787 | triclosan 2 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477870 | Antigen of Streptococcus pneumoniae Danish serotype 10A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477870 | Antigen of Streptococcus pneumoniae Danish serotype 10A capsular polysaccharide | Full form of descriptor (FN) | NO | |
RxCUI: 2477870 | Antigen of Streptococcus pneumoniae Danish serotype 10A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477870 | Antigen of Streptococcus pneumoniae Danish serotype 10A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477870 | Antigen of Streptococcus pneumoniae Danish serotype 10A capsular polysaccharide | Designated preferred name (PT) | NO | |
RxCUI: 2477871 | Antigen of Streptococcus pneumoniae Danish serotype 11A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477871 | Antigen of Streptococcus pneumoniae Danish serotype 11A capsular polysaccharide | Full form of descriptor (FN) | NO | |
RxCUI: 2477871 | Antigen of Streptococcus pneumoniae Danish serotype 11A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477871 | Antigen of Streptococcus pneumoniae Danish serotype 11A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477871 | Antigen of Streptococcus pneumoniae Danish serotype 11A capsular polysaccharide | Designated preferred name (PT) | NO | |
RxCUI: 2477872 | Antigen of Streptococcus pneumoniae Danish serotype 15B capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477872 | Antigen of Streptococcus pneumoniae Danish serotype 15B capsular polysaccharide | Full form of descriptor (FN) | NO | |
RxCUI: 2477872 | Antigen of Streptococcus pneumoniae Danish serotype 15B capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477872 | Antigen of Streptococcus pneumoniae Danish serotype 15B capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477872 | Antigen of Streptococcus pneumoniae Danish serotype 15B capsular polysaccharide | Designated preferred name (PT) | NO | |
RxCUI: 2477873 | Antigen of Streptococcus pneumoniae Danish serotype 17F capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477873 | Antigen of Streptococcus pneumoniae Danish serotype 17F capsular polysaccharide | Full form of descriptor (FN) | NO | |
RxCUI: 2477873 | Antigen of Streptococcus pneumoniae Danish serotype 17F capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477873 | Antigen of Streptococcus pneumoniae Danish serotype 17F capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477873 | Antigen of Streptococcus pneumoniae Danish serotype 17F capsular polysaccharide | Designated preferred name (PT) | NO | |
RxCUI: 2477874 | Antigen of Streptococcus pneumoniae Danish serotype 19A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477874 | Antigen of Streptococcus pneumoniae Danish serotype 19A capsular polysaccharide | Full form of descriptor (FN) | NO | |
RxCUI: 2477874 | Antigen of Streptococcus pneumoniae Danish serotype 19A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477874 | Antigen of Streptococcus pneumoniae Danish serotype 19A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477874 | Antigen of Streptococcus pneumoniae Danish serotype 19A capsular polysaccharide | Designated preferred name (PT) | NO | |
RxCUI: 2477875 | Antigen of Streptococcus pneumoniae Danish serotype 19A capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477875 | Antigen of Streptococcus pneumoniae Danish serotype 19A capsular polysaccharide conjugated | Full form of descriptor (FN) | NO | |
RxCUI: 2477875 | Antigen of Streptococcus pneumoniae Danish serotype 19A capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477875 | Antigen of Streptococcus pneumoniae Danish serotype 19A capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477875 | Antigen of Streptococcus pneumoniae Danish serotype 19A capsular polysaccharide conjugated | Designated preferred name (PT) | NO | |
RxCUI: 2477876 | Antigen of Streptococcus pneumoniae Danish serotype 2 capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477876 | Antigen of Streptococcus pneumoniae Danish serotype 2 capsular polysaccharide | Full form of descriptor (FN) | NO | |
RxCUI: 2477876 | Antigen of Streptococcus pneumoniae Danish serotype 2 capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477876 | Antigen of Streptococcus pneumoniae Danish serotype 2 capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477876 | Antigen of Streptococcus pneumoniae Danish serotype 2 capsular polysaccharide | Designated preferred name (PT) | NO | |
RxCUI: 2477878 | Antigen of Streptococcus pneumoniae Danish serotype 5 capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477878 | Antigen of Streptococcus pneumoniae Danish serotype 5 capsular polysaccharide | Full form of descriptor (FN) | NO | |
RxCUI: 2477878 | Antigen of Streptococcus pneumoniae Danish serotype 5 capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477878 | Antigen of Streptococcus pneumoniae Danish serotype 5 capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477878 | Antigen of Streptococcus pneumoniae Danish serotype 5 capsular polysaccharide | Designated preferred name (PT) | NO | |
RxCUI: 2477879 | Antigen of Streptococcus pneumoniae Danish serotype 9V capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477879 | Antigen of Streptococcus pneumoniae Danish serotype 9V capsular polysaccharide | Full form of descriptor (FN) | NO | |
RxCUI: 2477879 | Antigen of Streptococcus pneumoniae Danish serotype 9V capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477879 | Antigen of Streptococcus pneumoniae Danish serotype 9V capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477879 | Antigen of Streptococcus pneumoniae Danish serotype 9V capsular polysaccharide | Designated preferred name (PT) | NO | |
RxCUI: 2477880 | Antigen of Streptococcus pneumoniae serogroup 20 capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477880 | Antigen of Streptococcus pneumoniae serogroup 20 capsular polysaccharide | Full form of descriptor (FN) | NO | |
RxCUI: 2477880 | Antigen of Streptococcus pneumoniae serogroup 20 capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477880 | Antigen of Streptococcus pneumoniae serogroup 20 capsular polysaccharide | Designated preferred name (PT) | NO | |
RxCUI: 2477881 | Hevea brasiliensis latex | Designated preferred name (PT) | NO | |
RxCUI: 2477881 | Hevea brasiliensis latex | Full form of descriptor (FN) | NO | |
RxCUI: 2477882 | Guayule latex | Designated preferred name (PT) | NO | |
RxCUI: 2477882 | Guayule latex | Full form of descriptor (FN) | NO | |
RxCUI: 2477883 | Fluoroquinolone antibacterial agent | Designated preferred name (PT) | NO | |
RxCUI: 2477883 | Fluoroquinolone antibacterial agent | Full form of descriptor (FN) | NO | |
RxCUI: 2477884 | Melarsonyl | Designated preferred name (PT) | NO | |
RxCUI: 2477884 | Melarsonyl | Full form of descriptor (FN) | NO | |
RxCUI: 2477885 | Benzylpenicillin (as benzylpenicillin potassium) 5 million unit powder for solution for injection vial | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2477885 | Benzylpenicillin (as benzylpenicillin potassium) 5 million unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2477885 | Benzylpenicillin (as benzylpenicillin potassium) 5 million unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2477888 | labetalol Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2477889 | labetalol HCl 20 MG in 4 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2477889 | labetalol HCl 20 MG in 4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2477889 | labetalol HCl 20 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2477890 | labetalol hydrochloride 5 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477891 | Reltone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2477892 | ursodiol 200 MG [Reltone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2477893 | ursodeoxycholate Oral Capsule [Reltone] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2477894 | Reltone Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2477895 | Reltone Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2477896 | Reltone 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2477896 | Reltone 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2477896 | Reltone 200 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2477897 | ursodiol 400 MG [Reltone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2477898 | Reltone 400 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2477898 | Reltone 400 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2477898 | Reltone 400 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2477899 | etesevimab 35 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2477900 | etesevimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2477901 | etesevimab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2477902 | etesevimab 700 MG in 20 ML Injection (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2477902 | etesevimab 700 MG in 20 ML Injection (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2477902 | etesevimab 700 MG in 20 ML Injection (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2477903 | etesevimab 35 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2477910 | Hevea brasiliensis latex protein | Designated preferred name (PT) | NO | |
RxCUI: 2477910 | Hevea brasiliensis latex protein | Full form of descriptor (FN) | NO | |
RxCUI: 2477911 | Itraconazole trihydrochloride | Designated preferred name (PT) | NO | |
RxCUI: 2477911 | Itraconazole trihydrochloride | Full form of descriptor (FN) | NO | |
RxCUI: 2477912 | Lead and/or lead compound | Designated preferred name (PT) | NO | |
RxCUI: 2477912 | Lead and/or lead compound | Full form of descriptor (FN) | NO | |
RxCUI: 2477913 | Product manufactured as conventional release gas for inhalation (product) | Full form of descriptor (FN) | NO | |
RxCUI: 2477913 | Product manufactured as conventional release gas for inhalation (product) | Designated preferred name (PT) | NO | |
RxCUI: 2477935 | Alocane Max Strength | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2477936 | benzalkonium chloride 1.3 MG/ML / lidocaine hydrochloride 40 MG/ML [Alocane Max Strength] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2477937 | benzalkonium / lidocaine Topical Spray [Alocane Max Strength] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2477938 | Alocane Max Strength Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2477939 | Alocane Max Strength 4 % / 0.13 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2477939 | Alocane Max Strength 4 % / 0.13 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2477939 | Alocane Max Strength 4 % / 0.13 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2477950 | simethicone 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2477951 | simethicone 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2477951 | simethicone 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 247796 | ethinyl estradiol 0.05 MG / ethisterone 50 MG Sublingual Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247802 | ethanol 3.87 ML/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247805 | nystatin 100000 UNT/ML Vaginal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247808 | benzalkonium 33 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247809 | magnesium chloride 200 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247810 | triclosan 7.5 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247812 | zinc pyrithione 0.1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247812 | zinc pyrithione 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247812 | zinc pyrithione 0.1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247815 | APAP 325 MG / Caffeine 65 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247815 | APAP 325 MG / Caffeine 65 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247816 | acetaminophen 325 MG / caffeine 65 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 247816 | acetaminophen 325 MG / caffeine 65 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 247816 | acetaminophen 325 MG / caffeine 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247817 | sulfur 4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247817 | sulfur 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247817 | sulfur 4 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247818 | benzalkonium 115 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247819 | vit-C 450 MG / Calcium ascorbate 50 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247819 | vit-C 450 MG / Calcium ascorbate 50 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247819 | vit-C 450 MG / Calcium ascorbate 50 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247819 | vit-C 450 MG / Calcium ascorbate 50 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 24782 | Fatty-acyl-ethyl-ester synthase | Designated preferred name (PT) | NO | |
RxCUI: 24782 | Fatty-acyl-ethyl-ester synthase | Full form of descriptor (FN) | NO | |
RxCUI: 247820 | iodine 0.3 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247822 | cascara sagrada 32.4 MG / phenolphthalein 97.2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247823 | sodium phosphate, monobasic 330 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247824 | lidocaine 50 MG/ML / polymyxin B 10000 UNT Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247826 | benzocaine 6 % / resorcinol 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247826 | benzocaine 6 % / resorcinol 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247826 | benzocaine 6 % / resorcinol 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247827 | ASA 325 MG / Caffeine 16.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247827 | ASA 325 MG / Caffeine 16.2 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247828 | benzyl alcohol 0.25 ML/ML Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247829 | vitamin C 867 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247829 | vitamin C 867 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247829 | vitamin C 867 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247830 | vit-C 250 MG / Zinc Gluconate 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247830 | vit-C 250 MG / Zinc Gluconate 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247830 | vit-C 250 MG / Zinc Gluconate 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247833 | benzalkonium 130 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2478330 | simethicone 500 MG [Phazyme] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2478331 | Phazyme 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2478331 | Phazyme 500 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2478331 | Phazyme 500 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2478335 | evinacumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2478335 | evinacumab | Designated preferred name (PT) | YES | |
RxCUI: 2478335 | evinacumab | Full form of descriptor (FN) | YES | |
RxCUI: 2478335 | evinacumab | Designated preferred name (PT) | YES | |
RxCUI: 2478335 | evinacumab | Full form of descriptor (FN) | YES | |
RxCUI: 247835 | ethanol 62 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 247835 | ethanol 62 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 247835 | ethanol 62 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247835 | ethanol 62 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247836 | chloroxylenol 0.5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247836 | chloroxylenol 0.5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247836 | chloroxylenol 0.5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247837 | chloroxylenol 7 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247838 | fiber 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247839 | vitamin C 450 MG / zinc gluconate 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247839 | vitamin C 450 MG / zinc gluconate 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247839 | vitamin C 450 MG / zinc gluconate 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247840 | albuterol (as albuterol sulfate) 2 MG/ML Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247840 | albuterol (as albuterol sulfate) 2 MG/ML Inhalation Solution | Designated preferred name (PT) | NO | |
RxCUI: 247840 | albuterol (as albuterol sulfate) 2 MG/ML Inhalation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247840 | albuterol (as albuterol sulfate) 2 MG/ML Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247840 | albuterol (as albuterol sulfate) 2 MG/ML Inhalation Solution | Full form of descriptor (FN) | NO | |
RxCUI: 247840 | albuterol (as albuterol sulfate) 2 MG/ML Inhalation Solution | British preferred term (PTGB) | NO | |
RxCUI: 247843 | vit-C 150 MG / Zinc Gluconate 20 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247843 | vit-C 150 MG / Zinc Gluconate 20 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247843 | vit-C 150 MG / Zinc Gluconate 20 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2478430 | tofacitinib 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2478431 | tofacitinib Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2478432 | tofacitinib Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2478433 | tofacitinib 1 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2478433 | tofacitinib 1 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2478434 | tofacitinib 1 MG/ML [Xeljanz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2478435 | tofacitinib Oral Solution [Xeljanz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2478436 | Xeljanz Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2478437 | Xeljanz 1 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2478437 | Xeljanz 1 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2478437 | Xeljanz 1 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2478438 | umbralisib tosylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2478438 | umbralisib tosylate | Designated preferred name (PT) | NO | |
RxCUI: 2478438 | umbralisib tosylate | Full form of descriptor (FN) | NO | |
RxCUI: 2478439 | umbralisib | Full form of descriptor (FN) | YES | |
RxCUI: 2478439 | umbralisib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2478439 | umbralisib | Designated preferred name (PT) | YES | |
RxCUI: 2478439 | umbralisib | Full form of descriptor (FN) | YES | |
RxCUI: 2478439 | umbralisib | Designated preferred name (PT) | YES | |
RxCUI: 2478440 | umbralisib 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2478441 | umbralisib Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 2478441 | umbralisib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2478441 | umbralisib Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 2478442 | umbralisib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2478443 | umbralisib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2478444 | umbralisib 200 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 2478444 | umbralisib 200 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 2478444 | umbralisib 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2478444 | umbralisib 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2478445 | Ukoniq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2478446 | umbralisib 200 MG [Ukoniq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2478447 | umbralisib Oral Tablet [Ukoniq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2478448 | Ukoniq Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2478449 | Ukoniq Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2478450 | UKONIQ 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2478450 | UKONIQ 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2478450 | UKONIQ 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2478450 | UKONIQ 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2478451 | amylase 15200 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2478452 | protease 8800 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2478453 | amylase 15200 UNT / lipase 2600 UNT / protease 8800 UNT Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2478453 | amylase 15200 UNT / lipase 2600 UNT / protease 8800 UNT Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2478454 | amylase 15200 UNT / lipase 2600 UNT / protease 8800 UNT [Pancreaze] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2478455 | PANCREAZE 2,600 UNT / 15,200 UNT / 8,800 UNT Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2478455 | PANCREAZE 2,600 UNT / 15,200 UNT / 8,800 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2478455 | PANCREAZE 2,600 UNT / 15,200 UNT / 8,800 UNT Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2478456 | tigilanol tiglate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2478459 | evinacumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2478459 | evinacumab Injectable Product | Designated preferred name (PT) | YES | |
RxCUI: 2478459 | evinacumab Injectable Product | Full form of descriptor (FN) | YES | |
RxCUI: 247846 | calcium carbonate 158 MG / magnesium carbonate 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2478460 | evinacumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2478462 | Evkeeza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2478464 | evinacumab Injection [Evkeeza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2478465 | Evkeeza Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 247850 | psyllium 600 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247851 | fiber 539 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2478530 | carboxymethylcellulose sodium 0.5 % / glycerin 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2478530 | carboxymethylcellulose sodium 0.5 % / glycerin 1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 247854 | psyllium 435 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247855 | cascara sagrada 10 MG / phenolphthalein 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247857 | Silicones 20 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247857 | Silicones 20 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247858 | domiphen 0.0015 MG/MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247860 | caffeine 100 MG / glucose 420 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247861 | vitamin B1 10 MG/ML / vitamin B12 0.001 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247861 | vitamin B1 10 MG/ML / vitamin B12 0.001 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247861 | vitamin B1 10 MG/ML / vitamin B12 0.001 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247861 | vitamin B1 10 MG/ML / vitamin B12 0.001 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247862 | chloroxylenol 5 MG/ML Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247863 | zinc pyrithione 0.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247863 | zinc pyrithione 0.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247863 | zinc pyrithione 0.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2478630 | Bacillus coagulans 400000000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2478631 | Lactobacillus sporogenes 400,000,000 UNT Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2478631 | Lactobacillus sporogenes 400,000,000 UNT Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2478631 | Lactobacillus sporogenes 400,000,000 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2478632 | Bacillus coagulans 2000000000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2478633 | Lactobacillus sporogenes 2,000,000,000 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2478633 | Lactobacillus sporogenes 2,000,000,000 UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2478633 | Lactobacillus sporogenes 2,000,000,000 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2478646 | evinacumab-dgnb | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2478647 | evinacumab-dgnb 150 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2478648 | evinacumab-dgnb 345 MG in 2.3 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2478648 | evinacumab-dgnb 345 MG in 2.3 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2478648 | evinacumab-dgnb 345 MG in 2.3 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2478649 | evinacumab-dgnb 150 MG/ML [Evkeeza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 247865 | ferric chloride 6 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2478650 | Evkeeza 345 MG in 2.3 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2478650 | Evkeeza 345 MG in 2.3 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2478650 | Evkeeza 345 MG in 2.3 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2478651 | evinacumab-dgnb 150 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2478652 | evinacumab-dgnb 150 MG/ML Injection [Evkeeza] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 247867 | ASA 325 MG / Caffeine 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247867 | ASA 325 MG / Caffeine 4 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247868 | chloroxylenol 18 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247870 | dyphylline 500 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247871 | benzyl benzoate 200 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247873 | hexachlorophene 0.02 MG/MG Medicated Bar Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2478731 | evinacumab-dgnb 1200 MG in 8 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2478731 | evinacumab-dgnb 1200 MG in 8 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2478731 | evinacumab-dgnb 1200 MG in 8 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2478732 | Evkeeza 1200 MG in 8 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2478732 | Evkeeza 1200 MG in 8 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2478732 | Evkeeza 1200 MG in 8 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2478732 | Evkeeza 1200 MG in 8 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2478734 | hyaluronic acid 1.1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2478735 | glucosamine HCl 500 MG / hyaluronic acid 1.1 MG / dimethyl sulfone 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2478735 | glucosamine HCl 500 MG / hyaluronic acid 1.1 MG / dimethyl sulfone 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2478735 | glucosamine HCl 500 MG / hyaluronic acid 1.1 MG / dimethyl sulfone 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 247874 | zinc pyrithione 10 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247875 | benzocaine 10 MG/ML Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247876 | iodoxamid 99 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247877 | pancreatin 840 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247878 | ASA 325 MG / Caffeine 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247878 | ASA 325 MG / Caffeine 65 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247879 | aluminum acetate 0.5 % / benzethonium 0.03 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247879 | aluminum acetate 0.5 % / benzethonium 0.03 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247879 | aluminum acetate 0.5 % / benzethonium 0.03 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247879 | aluminum acetate 0.5 % / benzethonium 0.03 % Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 24788 | Lymphocyte antigen CD89 | Designated preferred name (PT) | NO | |
RxCUI: 24788 | Lymphocyte antigen CD89 | Full form of descriptor (FN) | NO | |
RxCUI: 247880 | iodine 0.12 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247885 | neomycin 500 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247886 | vit-B1 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247886 | vit-B1 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247886 | vit-B1 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247888 | vit-C 33.3 MG / Zinc Gluconate 33.3 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247888 | vit-C 33.3 MG / Zinc Gluconate 33.3 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247888 | vit-C 33.3 MG / Zinc Gluconate 33.3 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247890 | iodine 2.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247891 | vitamin B1 1.4 MG/ML / vitamin B12 0.002 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247891 | vitamin B1 1.4 MG/ML / vitamin B12 0.002 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247891 | vitamin B1 1.4 MG/ML / vitamin B12 0.002 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247891 | vitamin B1 1.4 MG/ML / vitamin B12 0.002 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247892 | ASA 325 MG / Caffeine 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247892 | ASA 325 MG / Caffeine 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247893 | benzalkonium 0.0015 MG/MG / ethanol 3.5 ML/ML Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2478941 | Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral capsule (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2478941 | Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral capsule (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 247895 | riboflavin 100 MG Oral Capsule | Full form of descriptor (FN) | NO | |
RxCUI: 247895 | riboflavin 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247895 | riboflavin 100 MG Oral Capsule | Designated preferred name (PT) | NO | |
RxCUI: 247895 | riboflavin 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2479030 | Fluzone Quadrivalent 2021 Southern Hemisphere vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2479030 | Fluzone Quadrivalent 2021 Southern Hemisphere vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2479030 | Fluzone Quadrivalent 2021 Southern Hemisphere vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2479031 | Fluzone Quadrivalent 2021 Southern Hemisphere | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2479032 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2021 Southern Hemisphere] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2479033 | influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2479034 | influenza virus vaccine 2021 (quadrivalent - Hong Kong/Victoria/Phuket/Washington) 0.25 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2479034 | influenza virus vaccine 2021 (quadrivalent - Hong Kong/Victoria/Phuket/Washington) 0.25 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2479034 | influenza virus vaccine 2021 (quadrivalent - Hong Kong/Victoria/Phuket/Washington) 0.25 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2479035 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2021 Southern Hemisphere] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2479036 | influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluzone Quadrivalent 2021 Southern Hemisphere] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2479037 | influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021 Southern Hemisphere] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2479038 | Fluzone Quadrivalent 2021 Southern Hemisphere vaccine 0.25 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2479038 | Fluzone Quadrivalent 2021 Southern Hemisphere vaccine 0.25 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2479038 | Fluzone Quadrivalent 2021 Southern Hemisphere vaccine 0.25 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2479039 | Fluzone Quadrivalent 2021 Southern Hemisphere Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2479040 | influenza A virus A/Victoria/2570/2019 (H1N1) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2479041 | Fluzone Quadrivalent 2021 Southern Hemisphere vaccine 0.5 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2479041 | Fluzone Quadrivalent 2021 Southern Hemisphere vaccine 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2479041 | Fluzone Quadrivalent 2021 Southern Hemisphere vaccine 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2479042 | influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2479043 | influenza virus vaccine 2021 (quadrivalent - Hong Kong/Victoria/Phuket/Washington) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2479043 | influenza virus vaccine 2021 (quadrivalent - Hong Kong/Victoria/Phuket/Washington) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2479043 | influenza virus vaccine 2021 (quadrivalent - Hong Kong/Victoria/Phuket/Washington) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2479044 | influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen / influenza A virus A/Victoria/2570/2019 (H1N1) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 2479045 | influenza virus vaccine 2021 (quadrivalent - Hong Kong/Victoria/Phuket/Washington) 0.5 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2479045 | influenza virus vaccine 2021 (quadrivalent - Hong Kong/Victoria/Phuket/Washington) 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2479045 | influenza virus vaccine 2021 (quadrivalent - Hong Kong/Victoria/Phuket/Washington) 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2479046 | sodium lauroyl methyl taurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 247906 | chloroxylenol 20 MG/ML Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247907 | chloroxylenol 2.5 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247909 | magnesium chloride 400 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247911 | iodine 0.75 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247911 | iodine 0.75 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247911 | iodine 0.75 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2479131 | Macrosyn | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2479132 | tulathromycin 100 MG/ML [Macrosyn] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2479133 | tulathromycin Injectable Solution [Macrosyn] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2479134 | Macrosyn Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2479135 | Macrosyn 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2479135 | Macrosyn 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2479135 | Macrosyn 100 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2479136 | lisocabtagene maraleucel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2479136 | lisocabtagene maraleucel | Designated preferred name (PT) | YES | |
RxCUI: 2479136 | lisocabtagene maraleucel | Full form of descriptor (FN) | YES | |
RxCUI: 2479136 | lisocabtagene maraleucel | Designated preferred name (PT) | YES | |
RxCUI: 2479136 | lisocabtagene maraleucel | Full form of descriptor (FN) | YES | |
RxCUI: 2479137 | lisocabtagene maraleucel 70000000 CELLS/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2479138 | lisocabtagene maraleucel Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2479138 | lisocabtagene maraleucel Injectable Product | Designated preferred name (PT) | YES | |
RxCUI: 2479138 | lisocabtagene maraleucel Injectable Product | Full form of descriptor (FN) | YES | |
RxCUI: 2479139 | lisocabtagene maraleucel Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2479140 | lisocabtagene maraleucel 70,000,000 CELLS/mL in 4.6 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2479140 | lisocabtagene maraleucel 70,000,000 CELLS/mL in 4.6 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2479140 | lisocabtagene maraleucel 70,000,000 CELLS/mL in 4.6 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2479141 | Breyanzi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2479142 | lisocabtagene maraleucel 70000000 CELLS/ML [Breyanzi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2479143 | lisocabtagene maraleucel Injection [Breyanzi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2479144 | Breyanzi Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2479145 | Breyanzi 70,000,000 CELLS/mL in 4.6 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2479145 | Breyanzi 70,000,000 CELLS/mL in 4.6 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2479145 | Breyanzi 70,000,000 CELLS/mL in 4.6 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2479145 | Breyanzi 70,000,000 CELLS/mL in 4.6 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2479146 | lisocabtagene maraleucel 70000000 CELLS/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2479147 | lisocabtagene maraleucel 70000000 CELLS/ML Injection [Breyanzi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2479147 | lisocabtagene maraleucel 70000000 CELLS/ML Injection [Breyanzi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2479149 | casirivimab 1332 MG in 11.1 mL Injection, 1 vial / imdevimab 1332 MG in 11.1 mL Injection, 1 vial (EUA) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2479149 | casirivimab 1332 MG in 11.1 mL Injection, 1 vial / imdevimab 1332 MG in 11.1 mL Injection, 1 vial (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 247915 | silicon dioxide 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2479150 | REGEN-COV, 2-cartons (casirivimab 1332 MG in 11.1 mL Injection, 1 vial / imdevimab 1332 MG in 11.1 MG Injection, 1 vial) (EUA) | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2479150 | REGEN-COV, 2-cartons (casirivimab 1332 MG in 11.1 mL Injection, 1 vial / imdevimab 1332 MG in 11.1 MG Injection, 1 vial) (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2479150 | REGEN-COV, 2-cartons (casirivimab 1332 MG in 11.1 mL Injection, 1 vial / imdevimab 1332 MG in 11.1 MG Injection, 1 vial) (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2479153 | casirivimab 300 MG in 2.5 mL Injection, 4 vial / imdevimab 300 MG in 2.5 MG Injection, 4 vial (EUA) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2479153 | casirivimab 300 MG in 2.5 mL Injection, 4 vial / imdevimab 300 MG in 2.5 MG Injection, 4 vial (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2479154 | REGEN-COV, 8-cartons (casirivimab 300 MG in 2.5 mL Injection, 4 vial / imdevimab 300 MG in 2.5 MG Injection, 4 vial) (EUA) | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2479154 | REGEN-COV, 8-cartons (casirivimab 300 MG in 2.5 mL Injection, 4 vial / imdevimab 300 MG in 2.5 MG Injection, 4 vial) (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2479154 | REGEN-COV, 8-cartons (casirivimab 300 MG in 2.5 mL Injection, 4 vial / imdevimab 300 MG in 2.5 MG Injection, 4 vial) (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2479155 | casirivimab 300 MG per 2.5 mL Injection, 1 vial / imdevimab 1332 MG in 11.1 MG Injection, 1 vial (EUA) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2479155 | casirivimab 300 MG per 2.5 mL Injection, 1 vial / imdevimab 1332 MG in 11.1 MG Injection, 1 vial (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2479156 | REGEN-COV, 5-cartons (casirivimab 300 MG in 2.5 mL Injection, 4 vial / imdevimab 1332 MG in 11.1 MG Injection, 1 vial) (EUA) | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2479156 | REGEN-COV, 5-cartons (casirivimab 300 MG in 2.5 mL Injection, 4 vial / imdevimab 1332 MG in 11.1 MG Injection, 1 vial) (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2479156 | REGEN-COV, 5-cartons (casirivimab 300 MG in 2.5 mL Injection, 4 vial / imdevimab 1332 MG in 11.1 MG Injection, 1 vial) (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2479158 | casirivimab 1332 MG in 11.1 mL Injection, 1 vial / imdevimab 300 MG in 2.5 MG Injection, 4 vial (EUA) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2479158 | casirivimab 1332 MG in 11.1 mL Injection, 1 vial / imdevimab 300 MG in 2.5 MG Injection, 4 vial (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2479158 | casirivimab 1332 MG in 11.1 mL Injection, 1 vial / imdevimab 300 MG in 2.5 MG Injection, 4 vial (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2479159 | REGEN-COV, 5-cartons (casirivimab 1332 MG in 11.1 mL Injection, 1 vial / imdevimab 300 MG in 2.5 MG Injection, 4 vial) (EUA) | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2479159 | REGEN-COV, 5-cartons (casirivimab 1332 MG in 11.1 mL Injection, 1 vial / imdevimab 300 MG in 2.5 MG Injection, 4 vial) (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2479159 | REGEN-COV, 5-cartons (casirivimab 1332 MG in 11.1 mL Injection, 1 vial / imdevimab 300 MG in 2.5 MG Injection, 4 vial) (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 247918 | vit-B1 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247918 | vit-B1 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247918 | vit-B1 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247920 | magnesium chloride 100 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247921 | magnesium carbonate 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247924 | magnesium chloride 12 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247927 | intrinsic factor 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247928 | aluminum chloride 100 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247930 | racepinephrine 2 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247931 | racepinephrine 80 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247935 | ASA 81 MG / Caffeine 8.1 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247935 | ASA 81 MG / Caffeine 8.1 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247936 | magnesium chloride 480 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247937 | magnesium chloride 25.4 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247938 | benzocaine 0.005 MG/MG / magnesium sulfate 0.6 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247941 | chloroxylenol 1 MG/ML Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247943 | glycerin 16 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247946 | aluminum sulfate 250 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247950 | iodine 10 MG/ML Douche | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247952 | calcium polycarbophil 400 MG / sennosides, USP 8.6 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2479540 | pimobendan Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2479541 | pimobendan 1.25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2479541 | pimobendan 1.25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2479542 | pimobendan Oral Capsule [Vetmedin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2479543 | Vetmedin 1.25 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2479543 | Vetmedin 1.25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2479543 | Vetmedin 1.25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2479544 | pimobendan 2.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2479544 | pimobendan 2.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2479545 | Vetmedin 2.5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2479545 | Vetmedin 2.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2479545 | Vetmedin 2.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2479546 | pimobendan 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2479546 | pimobendan 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2479547 | Vetmedin 5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2479547 | Vetmedin 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2479547 | Vetmedin 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2479549 | Quercus robur wood extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 247955 | magnesium chloride 71 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2479550 | Paulownia tomentosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2479551 | Cydonia oblonga leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2479553 | Cryptomeria japonica bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2479554 | Cupressus sempervirens bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2479555 | Stevia serrata flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2479556 | apple wood extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2479557 | octyldodecyl xyloside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 247956 | beta carotene 25000 UNT/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2479563 | labetalol hydrochloride 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2479564 | labetalol hydrochloride 200 MG in 200 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2479564 | labetalol hydrochloride 200 MG in 200 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2479564 | labetalol hydrochloride 200 MG in 200 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2479565 | labetalol hydrochloride 1 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2479566 | labetalol hydrochloride 100 MG in 100 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2479566 | labetalol hydrochloride 100 MG in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2479566 | labetalol hydrochloride 100 MG in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2479567 | labetalol hydrochloride 300 MG in 300 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2479567 | labetalol hydrochloride 300 MG in 300 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2479567 | labetalol hydrochloride 300 MG in 300 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2479569 | sodium phenyllactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 247958 | piperonyl butoxide 50.4 MG/ML / pyrethrins 6.3 MG/ML Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247959 | magnesium chloride 24 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247960 | bismuth camphocarbonate 150 MG / guaifenesin 250 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247960 | bismuth camphocarbonate 150 MG / guaifenesin 250 MG Rectal Suppository | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 247962 | ferric chloride 150 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247964 | aluminum chloride 0.2 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247968 | magnesium citrate 140 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2479688 | 3-phenyl-1-propanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2479689 | primycin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2479690 | trilaciclib | Full form of descriptor (FN) | YES | |
RxCUI: 2479690 | trilaciclib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2479690 | trilaciclib | Designated preferred name (PT) | YES | |
RxCUI: 2479690 | trilaciclib | Full form of descriptor (FN) | YES | |
RxCUI: 2479690 | trilaciclib | Designated preferred name (PT) | YES | |
RxCUI: 2479691 | trilaciclib dihydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2479691 | trilaciclib dihydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 2479691 | trilaciclib dihydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 247970 | aluminumm hydroxide 200 MG / magnesium hydroxide 150 MG per 5 ML Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247970 | aluminumm hydroxide 200 MG / magnesium hydroxide 150 MG per 5 ML Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2479702 | trilaciclib 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2479703 | trilaciclib Injectable Product | Full form of descriptor (FN) | YES | |
RxCUI: 2479703 | trilaciclib Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2479703 | trilaciclib Injectable Product | Designated preferred name (PT) | YES | |
RxCUI: 2479704 | trilaciclib Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2479705 | trilaciclib 300 MG Injection | Full form of descriptor (FN) | YES | |
RxCUI: 2479705 | trilaciclib 300 MG Injection | Designated preferred name (PT) | YES | |
RxCUI: 2479705 | trilaciclib 300 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2479705 | trilaciclib 300 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2479705 | trilaciclib 300 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2479706 | Cosela | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2479707 | trilaciclib 300 MG [Cosela] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2479708 | trilaciclib Injection [Cosela] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2479709 | Cosela Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2479710 | Cosela 300 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2479710 | Cosela 300 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2479710 | Cosela 300 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2479710 | Cosela 300 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2479725 | petrolatum 447 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2479726 | benzocaine 10 % / petrolatum 44.7 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2479726 | benzocaine 10 % / petrolatum 44.7 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2479726 | benzocaine 10 % / petrolatum 44.7 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247973 | benzocaine 6.5 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247973 | benzocaine 6.5 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 247973 | benzocaine 6.5 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2479730 | isopropyl alcohol 70 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2479730 | isopropyl alcohol 70 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2479730 | isopropyl alcohol 70 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247974 | APAP 325 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247974 | APAP 325 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247974 | APAP 325 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247978 | deanol 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247979 | ASA 325 MG / Phenobarbital 15 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 247979 | ASA 325 MG / Phenobarbital 15 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 247979 | ASA 325 MG / Phenobarbital 15 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247979 | ASA 325 MG / Phenobarbital 15 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2479830 | SARS-COV-2 (COVID-19) vaccine, vector - Ad26 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2479831 | Recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein only vaccine | Designated preferred name (PT) | YES | |
RxCUI: 2479831 | Recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein only vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2479831 | Recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein only vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2479831 | Recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein only vaccine | Full form of descriptor (FN) | YES | |
RxCUI: 2479832 | SARS-COV-2 (COVID-19) vaccine, vector - Ad26 100000000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2479833 | SARS-COV-2 (COVID-19) vaccine, vector non-replicating Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2479834 | SARS-COV-2 (COVID-19) vaccine, vector non-replicating Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2479835 | SARS-COV-2 (COVID-19) vaccine, vector - Ad26 0.5 ML Injectable Suspension (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2479835 | SARS-COV-2 (COVID-19) vaccine, vector - Ad26 0.5 ML Injectable Suspension (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2479835 | SARS-COV-2 (COVID-19) vaccine, vector - Ad26 0.5 ML Injectable Suspension (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 247990 | salicylic acid 20 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 247990 | salicylic acid 20 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 247990 | salicylic acid 20 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 247991 | salicylic acid 270 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247996 | pyrogallol 25 % / chlorobutanol 2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 247996 | pyrogallol 25 % / chlorobutanol 2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |